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The neurohormonal mechanisms underlying the regulation of extracellular osmolality are of 
critical physiological importance.  These mechanisms act to maintain the osmolality of human 
plasma close to a “set-point” of about 290 milliosmoles per litre. The magnocellular 
neurosecretory cells (MNCs) of the supraoptic nucleus (SON), synthesize and secrete the 
neurohypophysial hormones vasopressin (VP) and oxytocin (OT).  The primary hormonal 
regulator of osmolality is VP, which is released by the MNCs as a function of plasma osmolality 
and acts by controlling water reabsorption at the kidneys. MNCs decrease their volume and thus 
plasma membrane tension in response to acute increases in external osmolality and lack the 
compensatory mechanisms that limit volume changes in most cell types. This enables them to 
transduce changes in osmolality into changes in excitability via a mechanosensitive cation channel. 
It has been shown in vivo that sustained increases in plasma osmolality, however, cause marked 
hypertrophy of the MNCs that is part of a structural and functional adaptation that is thought to 
enable the MNCs to secrete large quantities of VP for prolonged periods. The mechanism of this 
important structural and functional adaptation of MNCs is difficult to address in an in vivo 
preparation and so an in vitro model of acutely isolated MNCs was used to pharmacologically 
assess the hypertrophy. It was observed that MNCs exposed to sustained hypertonic solutions, 
underwent an immediate shrinkage followed by a hypertrophy over 90 minutes and quickly 
recovered when reintroduced to isotonic conditions. This effect was found to depend on the size 
of the increase in osmolality, as smaller increases in osmolality resulted in smaller shrinkage and 
hypertrophy of the MNCs. Hypertrophy was shown to be independent of cell volume regulatory 
processes as inhibitors of the Na+-K+-Cl- cotransporter did not affect hypertrophy. Hypertrophy 
was also shown to be dependent on activation of phospholipase C (PLC) and protein kinase C 
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(PKC), as adding inhibitors of these enzymes to the hypertonic solution prevented hypertrophy. 
Hypertrophy could occur in isotonic conditions by inducing cell depolarization, increasing 
intracellular calcium ([Ca2+]i) and by activating PKC, thus showing each of these processes are 
involved in hypertrophy. Recovery from hypertrophy depends upon dynamin-mediated 
endocytosis as blocking dynamin function prevented recovery. In addition, exposing the MNCs to 
hypotonic solution resulted in an immediate enlargement followed by a sustained decrease in cell 
size. Finally, exposing acutely isolated MNCs to hypertonic solution for two hours resulted in a 
37% increase in the immunolabeling of the L-type Ca2+ channel CaV1.2 subunit. This increase in 
CaV1.2 immunolabeling does not depend on action potential firing as adding tetrodotoxin (TTX) 
to the hypertonic solution failed to prevent the increase. This project will help to elucidate the 
mechanisms underlying this interesting example of neuroendocrine adaptation and will help us to 
understand the regulation of body fluid balance during chronic challenges as seen in the elderly 
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CHAPTER 1: INTRODUCTION 
 
 
1.1. Osmolality and Osmoregulation 
 
The colligative properties of solutions are important elements of their physical properties and 
depend upon the amount of solute in a given amount of solvent (Pinarbasi et al., 2009). Among 
the colligative properties, osmotic pressure remains the most essential in cellular physiology 
(Sanger et al., 2001). In multicellular organisms, the electrolyte and organic molecule exchange 
occurs between the intracellular fluid (ICF) and extracellular fluid (ECF) (Fleischhauer et al., 
1995). The ICF comprises of the cell’s cytosol (Luby-Phelps, 1999) while the ECF consists of the 
interstitial fluid (between cells) and the blood plasma (Gauer et al., 1970). Electrolyte balance is 
imperative to maintain fluid balance within an organism (Rolls & Phillips, 1990) and the processes 
for maintenance occur for each body fluid compartment (Sawka & Montain, 2000). These 
processes include organ-level regulation by the renal system (filtration and reabsorption) (Bankir 
et al., 1989) and cellular-level regulation by osmosis, the flow of water from a region of higher 
concentration to lower concentration through passive diffusion (Metheny, 2011). At the level of 
cells, the plasma membrane is an important organelle that partitions the ECF from the ICF and 
allows water to travel across its membrane through specialized water pores (Curran & Solomon, 
1957). The osmolality indicates the moles of osmolytes (solutes such as proteins, small molecules 
and ions) in a given kilogram of solvent (mosmol kg-1) (Bourque et al., 2007). Osmolarity is an 
analogous measure, which indicates the moles of osmolytes in a given liter of solvent (mosmol L-
1) (Erstad, 2003).  
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Mammals are termed osmoregulators, which means that they maintain ECF osmolality near a set-
point (about 300 mosmol kg-1 in mammals) (Bourque, 2008). An ECF osmolality lower than 
normal is termed hypotonic while an osmolality higher is termed hypertonic. When the ECF 
undergoes osmotic changes, water flows through the cell membrane by means of osmosis to 
balance the ECF and ICF osmolality (Halperin & Skorecki, 1986; Bourque, 2008). This tendency 
to draw water between compartments is termed osmotic pressure and the difference in osmolalities 
between the two compartments is the driving force (Guyton & Hall, 2006; Boron & Boulpaep, 
2008). The most important cation in the ECF is sodium (Na+) (Terry, 1994) and the main regulatory 
processes that occur to maintain ECF osmolality do so by regulating Na+ and water (Guyton & 
Hall, 2006; Bourque, 2008). The regulation of Na+ levels can occur through changes in Na+ 
appetite (Weisinger et al., 1983; Blackburn et al., 1993) or through modification of Na+ excretion 
(natriuresis) (Huang et al., 1996; Andersen et al., 2002). Water levels can be altered through urine 
output (Verney, 1947; Bourque, 2008), thirst (Zerbe & Robertson, 1983; Baylis, 1987; Egan et al., 
2003; McKinley & Johnson, 2004), sweating (Fortney et al., 1984; Saat et al., 2005; Bourque, 
2008) and evaporation (Tucker, 1968). In mammals, homeostatic mechanisms employed during 
hyperosmotic challenges (dehydration or high salt consumption) include increased release of 
vasopressin (VP), a hormone that suppresses diuresis via increased renal water reuptake (Adolph 
& Ericson, 1927; De Wardener & Del Greco, 1955; Orloff et al., 1958; Guyton & Hall, 2006; 
Boron & Boulpaep, 2008) and motivation of water drinking (Thornton, 1986; Schoorlemmer et 
al., 2000). During conditions when the ECF is hypo-osmolar, the release of VP is reduced and 
subsequently the renal water reuptake is reduced, increasing the urine output (Guyton & Hall, 
2006; Bourque, 2008).  
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The significance of maintaining a physiological osmolality of the ECF can be evident during the 
acute changes that occur at the cellular level (Bourque & Oliet, 1997; Boron & Boulpaep, 2008; 
Bourque, 2008). When the ECF is hypo-osmolar, water will be drawn into cells and cause cell 
swelling (Lang et al., 1998b; Lang, 2007; Boron & Boulpaep, 2008). During hyperosmolar ECF 
conditions, water is drawn out of the cell causing it to shrink (Lang et al., 1998b; Lang, 2007; 
Boron & Boulpaep, 2008). The flow of water in and out of the cell is through water channels and 
is dictated by osmosis until the ICF and ECF equalize in osmolality (Lang et al., 1998b; Lang, 
2007; Boron & Boulpaep, 2008). As an adaptive process, many cells can undergo compensatory 
processes to counteract shrinkage and enlargement to maintain cell volume, known as regulatory 
volume increase (RVI) and regulatory volume decrease (RVD), respectively (Bourque & Oliet, 
1997; Lang et al., 1998a). The mechanisms employed against cell volume changes act by 
regulating internal osmolytes by transporting them across the cell membrane so that the osmolality 
of the ECF and ICF come to a balance (Lang et al., 1998a; Boron & Boulpaep, 2008). The 
maintenance of the ECF osmolality is crucial for the central nervous system, especially the brain, 
as extreme changes in volume can damage the tissue encased within the inflexible cranium 
(Bourque, 2008). When the osmolality changes, severe structural and functional damage can result 
leading to hyperexcitability and neuronal death (Bourque, 2008).  
1.1.1. Central and Peripheral Osmoreceptors  
Some aquatic animals have specific evolutionary adaptations that allow them to withstand changes 
to osmolality through optimization of cell volume regulatory mechanisms (Bourque, 2008; Aladin 
& Plotnikov, 2009). These animals are termed osmoconformers because the osmolality of their 
cells changes with the osmolality of their environment (Bourque, 2008). Osmoregulators, however, 
have specific homeostatic mechanisms that govern the ECF osmolality near a “set-point” 
 4 
 
(Bourque, 2008). This demonstrates that there are specific sensors in the organism that can detect 
changes in the ECF osmolality and subsequently govern the compensatory processes to attain 
osmotic homeostasis (Bourque & Oliet, 1997; Bourque, 1999; Bourque et al., 2007; Bourque, 
2008).  
It has been shown that infusions of hypertonic solutions cause cellular dehydration, and that this 
is necessary to induce VP release and stimulate the thirst response (Gilman, 1937; Verney, 1947). 
Later studies documented the existence of specific osmoreceptor cells that can detect the ECF 
osmolality changes and showed that these cells reside within the brain (Jewell & Verney, 1957). 
Based on the fact that the cells are neuronal cells that can detect changes in ECF osmolality, 
researchers concluded that it is the cell’s resting electrical activity that defines the set-point of ECF 
osmolality (Bourque, 2008). The cell’s resting membrane potential can be governed by membrane 
stretching, which can be transduced into changes in ion channel activity and membrane potential 
(Verney, 1947; Bourque, 2008). Thus changes in osmolality result in changes in the tendency to 
fire action potentials (Bourque, 2008). Early studies documented the effects of inducing 
hypertonicity in blood plasma as an effective stimulator for thirst (Bourque et al., 1994). Other 
studies have shown that the thirst response is dependent upon changes in cell volume (water efflux 
from cytoplasm), as permeable osmolytes are not able to induce the thirst response (Gilman, 1937). 
This was an instrumental finding suggesting the individual cell size changes can induce the 
osmoregulatory behaviour. It was not certain, however if this was the collective response from all 
cells in the animal or if there were cells that were specific for sensing changes in osmolality 
(Bourque et al., 1994; Bourque, 2008).  
One of the first studies attempting to identify the location of central nervous system osmoreceptors 
showed that VP could be released by increasing the carotid artery blood osmolality by 1% (Verney, 
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1947). Using surgical methods to isolate arterial blood supplies, they found that the site for osmotic 
receptors were found in the ventral area of the hypothalamus (Verney, 1947). This specific site 
within the hypothalamus contains the supraoptic and paraventricular nuclei (SON and PVN), 
which have the magnocellular neurosecretory cells (MNCs) (Verney, 1947; Bourque & Oliet, 
1997; Bourque, 2008). As an extension to the findings it was found that osmolytes impermeable 
to the blood-brain barrier do not affect urine output (diuresis) suggesting that the central sites of 
osmoreception must be located in areas that do not have a blood-brain barrier (Thrasher et al., 
1980). This finding led to the investigation of numerous sites within the neural circumventricular 
organs such as the organum vasculosum of the lamina terminalis (OVLT) and the subfornical 
organ (SFO) and that lesions in these sites impair neurohormonal regulation of plasma osmolality 
(Thrasher et al., 1980). It has been shown that the OVLT and SFO innervate the MNCs through 
the median preoptic nucleus (MnPO) and that the electrical and hypertonic stimulation of these 
upstream areas can cause excitation in the MNCs and the release of VP and oxytocin (OT) 
(Bourque et al., 1994).  
This neural circuitry is known to underlie the central nervous system control of osmoregulation. 
Osmoregulatory behaviours such as thirst can take time to cause a change in plasma osmolality 
but thirst can be quenched and osmoregulatory hormonal influences can change much before 
(Bourque et al., 1994). This observation suggests the possibility of peripheral osmoreceptors that 
can detect changes peripherally before a systemic change in osmolality can be detected by central 
osmoreceptors (Bourque et al., 1994). It is known that absorption of osmolytes and fluids is 
through the splanchnic mesentery artery, hepatic portal vein, liver and finally to the systemic 
circulation (Boron & Boulpaep, 2008). This finding led to the possibility that the peripheral 
osmoreceptors may be present somewhere in these sites (Bourque et al., 1994). It has been shown 
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that infusing water or hypertonic saline into the hepatic portal vein, causes increases and decreases 
in diuresis respectively and that this can change the electrical activity of MNCs and the subsequent 
release of VP (Haberich, 1968). Electrophysiological studies have confirmed that the hepatic 
branch of the vagus nerve has modulated firing patterns after changes in the osmolality of the 
hepatic portal circulation (Adachi et al., 1976). The location of these peripheral receptors makes 
them very important in anticipating the osmotic effects of the nutrients and fluids absorbed 
allowing the osmoregulatory processes to buffer these changes (Bourque et al., 1994). Further, it 
has been shown in mice that afferent projections in the thoracic dorsal root ganglion have 
innervations and nerve endings in the hepatic portal system (Choi-Kwon & Baertschi, 1991). This 
confirms findings showing functional osmosensation in the peripheral hepatic circulation. The 
transduction mechanism to sense changes in osmolality are electrical and are dependent upon an 
osmotically sensitive ion channel, the transient receptor potential vanilloid 4 (TRPV4) channel as 
peripheral osmoreceptors of TRPV4 knockout mice were no longer activated with osmolality 
changes (Lechner et al., 2011). Other peripheral osmoreceptors sites include within the 
gastrointestinal tract (Dooley & Valenzuela, 1984; Carlson et al., 1997) and the oropharyngeal 
cavity (Kuramochi & Kobayashi, 2000). 
1.1.2. Magnocellular Neurosecretory Cells (MNCs)  
The MNCs are central osmoreceptors that synthesize and secrete the hormones VP and (OT) into 
the general circulation (Swaab et al., 1975). The MNCs are located in the hypothalamic regions of 
the SON and PVN with an total abundance of about 10,000 in rats (Rhodes et al., 1981) and 
100,000 in humans (Manaye et al., 2005). The SON primarily contains MNCs with astrocytes 
(Tweedle & Hatton, 1977; Theodosis & Poulain, 1984)  and few interneurons (Hatton, 1990; 
Armstrong, 1995) between the MNCs. MNCs synthesize either OT or VP (Sofroniew, 1982), and 
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send a single axon to the posterior pituitary gland through the median eminence (Brownstein et 
al., 1980). This bundle of OT and VP MNC axons is known as the hypothalamic-neurohypophysial 
tract. It is at the posterior pituitary that they secrete their hormones into the rich blood plexus 
(Brownstein et al., 1980). Each axon ramifies into 2,000 – 10,000 terminals, which are dense in 
OT or VP containing vesicles (Brownstein et al., 1980; Meeker et al., 1991). The MNCs possess 
between one to three dendrites (Stern & Armstrong, 1998), most of which project to the ventral 
glial lamina (Armstrong & McNeill, 1982). The release of OT and VP can also occur through the 
dendrites as the presence of neurosecretory vesicles have been detected there (Ludwig, 1998b). In 
addition to secretion of neurohypophysial hormones from the axon terminals studies have shown 
release from the somatodendritic regions, which is thought to have an important role in regulating 
function of MNCs (Ludwig, 1998b). The release of these neuropeptides is shown to have an 
autocrine and paracrine role as MNCs express the receptors for the neuropeptides and their 
activation leads to an increase in intracellular calcium [Ca2+]i (Lambert et al., 1994; Dayanithi et 
al., 1996). Other somatodendritic secretions by MNCs include the opioid dynorphin (Whitnall et 
al., 1983) and nitric oxide (through nitric oxide synthase) (Kadowaki et al., 1994). Dynorphin has 
a role in terminating phasic firing (Brown & Bourque, 2004) and diminishes VP release (Brown 
et al., 1999). The roles of nitric oxide in MNCs may include modulation of electrical firing patterns 
(Liu et al., 1997) and an action on afferent neurons to modulate presynaptic transmission (Cui et 
al., 1994). 
1.1.2.1. Morphology 
MNCs can be isolated and identified using methods that have been well established (Oliet & 
Bourque, 1992; Armstrong, 1995). As the name suggests, MNCs are large and 96% of cells 
isolated from the SON region that have a cross sectional area more than 160 µm2 are MNCs (Oliet 
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& Bourque, 1992). The commonly used protocols for in vitro enzymatic separation of MNCs from 
a single block of SON tissue has been shown to yield about 2-10% of the total cell number (100 – 
500 MNCs) from rats (Oliet & Bourque, 1992). 
1.1.2.2. Neurohypophysial Hormones 
 
The primary role of MNCs is to synthesize and secrete OT and VP, which are hormones serving 
important roles in mammalian physiology and homeostasis (Swaab et al., 1975; Bourque, 2008). 
The hormone VP plays a prominent role in osmoregulation by modulating urine output through its 
actions on the kidney collecting ducts (Guyton & Hall, 2006; Boron & Boulpaep, 2008). A minor 
role of VP is thermoregulation by modulating renal water uptake (Sharif-Naeini et al., 2008). VP 
is also a vasoconstrictor that increases blood pressure by increasing arterial resistance (Toba et al., 
1991; Bourque, 2008). VP also has effects on behaviour including regulating thirst (Thompson et 
al., 1987) and when released in the central nervous system is has roles in memory consolidation 
(Gash & Thomas, 1983; Gispen, 2011) and sexual mood (Murphy et al., 1987). VP performs its 
physiological roles by acting on V1a, V1b, and V2 G-protein coupled receptors (GPCRs) (Ball, 
2007). The V1a receptor is expressed on MNC plasma membranes and its activation causes 
autocrine inhibition of VP release. Antagonism of V1a receptors switches the MNCs from silent to 
phasic firing (Ludwig & Leng, 1997; Brown et al., 2004). Aquaporins are a class of carrier protein 
that facilitate water transport governed by osmotic forces (Agre, 2006). In the kidneys of 
mammals, aquaporin-2 (AQP2), aquaporin-3 (AQP3) and aquaporin-4 (AQP4) are specifically 
implicated in the water reabsorption process (Ball, 2007). At the cellular level of water 
homeostasis, VP acts on the V2 receptor in the kidney and causes cyclic adenosine monophosphate 
(cAMP)-dependent translocation of AQP2 to the apical membrane of the collecting duct, via 
exocytotic fusion of vesicles containing AQP2 (Agre, 2006; Petersen, 2006; Ball, 2007). The 
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basolateral membrane contains AQP3 and AQP4, which allow water in the cell to depart to the 
surrounding ECF (Agre, 2006; Petersen, 2006; Ball, 2007). During normal conditions, the blood 
VP concentration is about 1-3 pg/mL (Forsling et al., 1998) and the maintenance of that range 
induces renal water reabsorption of about 30 liters a day (Forsling et al., 1998).  
OT is a hormone that is involved mainly in female physiology of mammals, including lactation 
and the milk letdown reflex (Moon & Turner, 1959; Guyton & Hall, 2006; Boron & Boulpaep, 
2008). OT is also known for its physiological role in inducing uterine contractions during labour 
(Takayanagi et al., 2005; Boron & Boulpaep, 2008). OT is also involved in modulating behaviour 
including sexual arousal in men (Murphy et al., 1987) and women (Blaicher et al., 1999), and has 
a calming effect (high trust, low fear) (Kirsch et al., 2005; Theodoridou et al., 2009; Cardoso et 
al., 2013; Lane et al., 2013). In males, OT is known to be involved in contraction for sperm motility 
in the epididymis (Studdard et al., 2002; Gupta et al., 2008). The normal amounts of circulating 
OT is similar to VP, about 1-3 pg/mL (Forsling et al., 1998). Physiological levels of OT is shown 
to have a natriuretic role in rats (Verbalis et al., 1991). OT and VP are produced and packaged into 
secretory vesicles in the MNC cell bodies, then subsequently carried to the axon terminals of 
MNCs in the posterior pituitary (Theodosis et al., 1978; Bicknell, 1988). During release of the 
hormones, the action potentials generated cause activation of voltage-gated Ca2+ channels 
(VGCCs), which allows Ca2+ influx, exocytotic fusion of the neuropeptide vesicles and release 
into the plexus of blood vessels in the posterior pituitary (Hatton, 1990; Armstrong, 1995). 
1.1.2.3. MNC Electrical Activity  
 
MNCs are neuronal cells that can detect changes in ECF osmolality (Bourque et al., 2007; 
Bourque, 2008). Thus changes in osmolality result in changes in the membrane potential and the 
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tendency to fire action potentials (Oliet & Bourque, 1992; Bourque et al., 2007; Bourque, 2008; 
Sharif-Naeini et al., 2008) and hormone output (Bicknell, 1988). Under isotonic ECF conditions, 
the action potential firing is about 1-3 Hz, which is considered small and arrhythmic (Poulain & 
Wakerley, 1982; Bourque & Oliet, 1997). The activity pattern of MNCs changes during increases 
of as little as 3 mosmol/kg to more continuous and rapid firing (Poulain & Wakerley, 1982; 
Bourque & Oliet, 1997). The third pattern, phasic firing, is the most effectual for rapid secretion 
of VP from the axon terminals (Leng et al., 1999; Brown et al., 2013). Increases in osmolality also 
increase firing in OT MNCs (Brimble & Dyball, 1977; Brimble et al., 1978), and this may be 
important in osmoregulation due to the effect of OT on natriuresis (Verbalis et al., 1991). In phasic 
firing, MNCs fire for about 15 seconds followed by silent periods of about 10 seconds. At the 
beginning of each burst, MNCs display rapid firing (15-25 Hz) followed by slower firing (about 6 
Hz) lasting till the end of the burst (Poulain & Wakerley, 1982; Brown, 2004; Brown & Bourque, 
2006; Brown et al., 2013). Phasic firing is the most efficient pattern for evoking hormone release 
because during continuous firing (>10 seconds) the release fatigues, which then recovers after a 
rest period (Bicknell et al., 1984; Brown et al., 2013). The firing patterns of MNCs are due to 
various intrinsic and extrinsic modulators (Brown et al., 2013). Intrinsic factors include specific 
currents based on osmolality (stretch-inactivated cation channels; SICs) and activity-dependence 
(afterpotentials) (Oliet & Bourque, 1993a; Oliet & Bourque, 1993b).  
The ability of MNCs to transduce changes in osmolality into changes in electrical potential is a 
property that is mediated through specific SICs (Oliet & Bourque, 1993b). On a physical level, 
osmolality changes cause cell shrinkage or enlargement during hypertonic and hypotonic 
conditions and it is these changes in cell size that are key to electrophysiological changes (Bourque, 
2008). The SICs are plasma membrane channels that respond to membrane tension and so applying 
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positive pressure in a patch clamp setup mimics cell swelling and results in closing of the SICs 
causing hyperpolarization, lower action potential firing and reduced hormone release (Oliet & 
Bourque, 1993b; Bourque, 2008). In hypertonic conditions during MNC shrinkage, there is lower 
plasma membrane tension and so the SICs open and allow cation influx, increased action potential 
generation and increased hormone output (Oliet & Bourque, 1993b; Bourque, 2008). The 
mechanosensitivity of MNCs involves actin filaments as actin polymerization affects the 
mechanosensitivity of MNCs (Zhang et al., 2007b; Bourque, 2008). The SIC is an ion channel that 
is part of the TRPV family. It is thought to be a specific N-terminal splice variant of TRPV1 
(Sharif-Naeini et al., 2008). The inability of TRPV1 knockout mice MNCs to be osmosensitive 
(i.e. to display osmolality-dependent cell activity) and inability to release normal amounts of VP, 
demonstrates the important role of SICs in transducing osmolality information into electrical 
signals (Sharif-Naeini et al., 2008).  
A recently identified osmosensitive current, the OKC, is a voltage-gated K+ channel that may be 
important in regulating the firing patterns seen in MNCs (Zhang et al., 2009). The role of the OKC 
is not completely clear as an osmolality-dependent outward K+ current would be expected to 
hyperpolarize the cell rather than induce cell firing (Zhang et al., 2009). An alternate hypothesis 
is that the OKC might be involved in maintaining the silent phase during phasic firing or at least 
slow the phasic firing activity to reach the silent phase (Zhang et al., 2009).  
The phasic burst firing pattern is very important in maximal hormonal release (Leng et al., 1999) 
and their generation depends on both glutamatergic excitatory postsynaptic potentials and 
depolarizing afterpotentials (DAP) (Andrew & Dudek, 1983; Israel et al., 2010). These DAPs are 
dependent on activity and are regulated by the membrane’s intrinsic properties (Andrew & Dudek, 
1983). [Ca2+]i plays an important role in phasic firing by activating DAPs (Li et al., 1995). MNCs 
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also have intrinsic currents that hyperpolarize the cell (inhibitory currents) including 
hyperpolarizing afterpotentials (HAP) and afterhyperpolarizing afterpotentials (AHP) (Armstrong 
et al., 1994). These inhibitory currents are modulated by Ca2+-dependent potassium (K+) channels 
(Andrew & Dudek, 1983; Armstrong et al., 1994). MNCs have silent phases and the mechanism 
of the termination of the bursts and prolonged silence are not completely understood (Andrew & 
Dudek, 1983; Roper et al., 2004; Brown et al., 2006), however the HAP and AHP could be 
involved in burst termination (Brown et al., 2013). In addition, it was observed that dendritic 
release of dynorphin and activation of κ-opioid receptors, terminates phasic firing by decreasing 
the plateau potential and the probability of further spikes (Brown et al., 2006). Thus the 
depolarizing DAP and hyperpolarizing HAP and AHP currents are involved in modulating MNC 
electrical activity in an activity-dependent manner to ensure maximal and efficient release of 
hormones. Extrinsic signaling from other neuronal populations, such as those in the OVLT, also 
serves to modulate MNC electrical activity and is a requirement for phasic firing patterns (Yang 
et al., 1994; Richard & Bourque, 1995). The intrinsic and extrinsic activity modulations serve to 
regulate action potential firing, which is required for VGCC opening and hormonal output into the 
general circulation (Bourque et al., 1994; Bourque & Oliet, 1997; Bourque, 2008).  
Ca2+ is a very important ion in cellular physiology and specific mechanisms are in place to maintain 
Ca2+ homeostasis (Carafoli, 1987). A very important role of Ca2+ is in second messenger systems 
that are involved in maintaining cellular functions during physiological and pathophysiological 
states (Petersen et al., 2005). Ca2+ is buffered inside the cell within the endoplasmic reticulum 
(ER) (Koch, 1990) and is kept at intracellular concentrations of about 100 nM, a 106 dilution from 
the extracellular concentrations of 1-2 mM (Clapham, 2007). The mitochondrion requires Ca2+ for 
its oxidative phosphorylation activity and can be another buffering compartment for Ca2+ 
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(Zamponi, 2005). The reason that [Ca2+]i is kept so low is because Ca
2+ is involved in so many 
intracellular processes (Berridge et al., 2003). When Ca2+ is required, it may rise to 400 nM or 
more (Wong et al., 1991). In vertebrates, Ca2+ is important in bone as the phosphate and sulfate 
salt and it presents a very important reservoir for ECF Ca2+ when required (Ham, 1932; Boron & 
Boulpaep, 2008). Ca2+ has many prominent roles in various cell types such as neurotransmission 
in neurons (Ross, 1989), contraction in myocytes (Cheung et al., 1982), vasodilation in endothelial 
cells (Cauvin et al., 1983), and activation of the T-cell response in the immune system (Birx et al., 
1984). The entry of Ca2+ is through numerous membrane receptors such as TRP channels 
(Birnbaumer et al., 1996), N-methyl D-aspartate receptors (NMDARs) (Bauer et al., 2002) and 
VGCCs (Catterall et al., 2005). VGCCs are important ports of Ca2+ entry that open in response to 
a depolarizing cell voltage (Catterall et al., 2005). The VGCCs are very selective for Ca2+ (Catterall 
et al., 2005). Each channels consists of an α1-subunit along with a γ-subunit, a β-subunit (except 
T-type) and a α2-δ complex (Catterall et al., 2005). The α1-subunit is important for voltage sensing 
and for the Ca2+ selective pore (Catterall et al., 2005). Different types of VGCCs exist including 
L-, N-, P-, Q-, R- and T-types which are well documented through electrophysiological, 
biophysical and pharmacological studies (Goldin et al., 2000; Catterall et al., 2005). The VGCCs 
are expressed in MNCs soma (T-, L-, R-, P- and N-) and nerve terminals (L-, N-, and Q-) (Fisher 
& Bourque, 1996; Fisher et al., 2000).  
Of particular importance to neuronal populations is the L-type Ca2+ channel, which is part of the 
CaV1 family (Goldin et al., 2000; Catterall et al., 2005). They play roles in neuronal plasticity 
(Galewski et al., 1992; Hendricson et al., 2003; Fossat et al., 2007), neurotransmitter secretion 
(Perney et al., 1986; Westenbroek et al., 1990; Catterall, 1998) and development (Lipscombe et 
al., 2004). Two main subtypes of L-type Ca2+ channels, CaV1.2 and CaV1.3, have been shown 
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through gene expression studies (Glasgow et al., 2000) and immunohistochemistry (Joux et al., 
2001) to be present in MNC soma and axon terminals. Together, the L-type Ca2+ channels are 
responsible for about 25% of all the VGCC currents (Fisher & Bourque, 1995, 1996; Foehring & 
Armstrong, 1996). In other cell types, they are implicated in gene expression (Chung & Jan, 2006) 
and cell division (Loechner et al., 2010). The gene expression regulatory control by CaV1.2 and 
CaV1.3 is due to the C-terminus of both channel subtypes, which allow them to interact with cAMP 
response element binding (CREB) protein (Burbach et al., 2001). The C-terminus of CaV1.2 can 
act as a transcriptional regulator when transported to the nucleus (Burbach et al., 2001). 
Pharmacological blockers of L-type Ca2+ channels include dihydropyridines and 
phenylalkylamines (Schuster et al., 1996; Lipkind & Fozzard, 2003).  
1.2 Osmotic Adaptations  
With the evolution of the nervous system and in vertebrates with a stiff cranium, neuronal 
physiological processes are very much reliant on the chemical and physical environment (Bourque, 
2008). Osmoregulators maintain ECF osmolality by active regulation of ionic concentrations to 
achieve isotonic ECF conditions and by specialized neuronal homeostatic control (Lang et al., 
1998a; Bourque, 2008). This section will discuss some of the structural and functional adaptations 
in both short and long term exposure to osmotic changes. 
1.2.1 Short-term adaptations  
MNCs are able to detect and modulate their physiological activity and hormonal output during 
short term changes in osmolality (Bourque et al., 1994; Zhang & Bourque, 2003; Brown & 
Bourque, 2006; Bourque, 2008). The MNCs use SICs to transduce the change in osmolality to a 
change in electrical activity (Oliet & Bourque, 1993b; Sharif-Naeini et al., 2008). All cells, 
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including MNCs, shrink immediately following exposure to hypertonic solutions and this 
shrinkage relieves membrane tension and subsequently opens SICs (Oliet & Bourque, 1993b; 
Zhang & Bourque, 2003). This opening of the SICs allows influx of cations, depolarization, and 
action potential firing (Bourque, 2008). During hypo-osmotic exposure, the cells swell, increasing 
membrane tension and closing the SICs, resulting in hyperpolarization and decreased MNC cell 
firing (Bourque, 2008).  
Animals have evolved cellular pathways to counteract the acute volume changes; these are termed 
regulated volume increase (RVI) and regulated volume decrease (RVD) (Lang et al., 1998a; Lang, 
2007). During the initial phase of a cell in a hypertonic solution, osmosis dictates that water will 
rush out of the cell due to the newly established osmotic gradient and cause overall cell shrinkage 
(Lang et al., 1998b; Lang, 2007). As outlined, the cell will undergo RVI, which occurs primarily 
by ion influx to re-establish the inner osmotic strength which preserves the remaining water (Lang 
et al., 1998a; Lang, 2007). The shrinkage of the cell leads to the activation of specific channels 
and cotransporters involved in cell volume regulation, such as the Na+-K+-2Cl- cotransporter, 
Na+/H+ exchanger and the Cl-/HCO3
- exchanger (Lang et al., 1998b). Both the Na+/H+ exchanger 
and Cl-/HCO3
- exchanger act to replenish intracellular NaCl, while the excess Na+ (through the 
Na+-K+-2Cl- cotransporter or Na+/H+ exchanger) is extruded by a Na+/K+ ATPase leading to a net 
influx of KCl (Lang et al., 1998b; Gamba, 2005). Some Na+ channels may activate and the 
depolarization causes Cl- influx. (Lang et al., 1998b; Wehner et al., 2003). 
When cells are exposed to hypo-osmolar conditions, osmosis determines that water will rush in to 
equilibrate the ICF and ECF osmolality causing cellular swelling (Bourque, 2008). To protect from 
further expansion, the cells recruit RVD processes, which act by extruding K+ and other anions 
(Okada, 2006; Wehner, 2006). The main K+ channels involved in its efflux are KV1.3 and KV1.5 
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and anion channels include the chloride channels ClC-2 and ClC-3 (Lang et al., 1998b). The 
increased membrane tension may also activate stretch-activated cation channels, which may 
indirectly lead to K+ efflux by Ca2+ entry and subsequent activation of Ca2+-sensitive K+ channels 
(Lang et al., 1998b; Lang, 2007). In human salivary gland cells, swelling results in release of 
adenosine triphosphate (ATP), which acts in a autocrine fashion on purinergic receptors (P2Y2) 
causing Ca2+ release and opening of K+ channels (Ryu et al., 2010). 
In addition to cell volume regulation, the electrophysiological properties of MNCs also change 
during short term osmotic stress. The cell capacitance represents the charge separation capacity of 
a cell and this is dependent upon the cellular membrane surface area (Hille, 2001; Partridge & 
Partridge, 2003; Boron & Boulpaep, 2008; Bourque, 2008). This electrophysiological parameter 
can be monitored and can give important information on cellular morphometry and the dynamics 
of cellular membranes during the course of a hypertonic or hypotonic shock (Boron & Boulpaep, 
2008; Bell & Rhoades, 2009). Exposure to hypotonic and hypertonic solutions causes a respective 
decrease and increase in MNC conductance (Bourque & Oliet, 1997). Changes in cell volume and 
conductance occur on similar time frames and are both reversible (Bourque & Oliet, 1997). The 
effect of short term osmotic changes of MNCs on morphometry and capacitance are different than 
those of non-osmosensitive neurons such as hippocampal neurons (Zhang & Bourque, 2003). 
When exposed to hypotonic or hypertonic solutions, MNCs and hippocampal neurons displayed 
the normal cellular swelling or shrinkage, respectively (Zhang & Bourque, 2003; Bourque, 2008). 
It was noted however that over time, during slow osmotic ramps the hippocampal neuron volume 
did not fluctuate significantly, indicating that RVI and RVD operate in non-MNC neurons (Zhang 
& Bourque, 2003). In experiments with a fast step of hypotonic exposure, both MNCs and 
hippocampal neurons showed rapid swelling, which was maintained in MNCs, but hippocampal 
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neurons showed recovery starting about 100 seconds after exposure, further indicating the rapid 
RVD seen in these cell types (Zhang & Bourque, 2003). In the reverse condition of a fast 
hypertonic exposure, both MNCs and hippocampal neurons shrunk but the hippocampal neurons 
shrunk less, indicating a dynamic and fractional RVI (Zhang & Bourque, 2003). These data suggest 
that MNCs lack the cell volume regulatory processes which protect most other cell types from 
swelling and shrinkage (Zhang & Bourque, 2003). Since MNCs are osmoreceptors which rely on 
membrane tension to encode the ECF osmolality, the lack of volume compensatory processes are 
thought to allow SICs to transduce the changes in ECF osmolality to changes in electrical activity 
and thus hormone output (Zhang & Bourque, 2003).  
1.2.1.1 Activation of PLC and changes in PIP2 levels  
 
 
The plasma membrane is made of many phospholipids, including phosphatidylinositol 4,5-
bisphosphate (PIP2), which is an important precursor to other second messenger molecules (Hokin, 
1985; Raucher et al., 2000; Boron & Boulpaep, 2008). Phospholipase C (PLC) is a membrane-
associated protein that cleaves PIP2 into inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG) 
(Wong et al., 2005; Boron & Boulpaep, 2008). The DAG remains in the membrane and the IP3 
diffuses to the smooth endoplasmic reticulum (SER) to act on IP3 receptors to release Ca
2+ stores 
(Wong et al., 2005; Boron & Boulpaep, 2008). This combination of a rise in [Ca2+]i with DAG 
activates protein kinase C (PKC), which via phosphorylation causes modulation of many cellular 
events (Bell, 1986). Besides being a precursor molecule, PIP2 is well known to anchor cytosolic 
proteins (McLaughlin et al., 2002), regulate over 30 ion channels (Suh & Hille, 2008), and to have 
roles in cytoskeletal functions (Raucher et al., 2000; Logan & Mandato, 2006) and membrane 
trafficking (Hilgemann et al., 2001).  
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There are three groups of isoforms of PLC, PLCβ, PLCγ and PLCδ, all of which have a range of 
requirements and mechanisms of activation that are specific to their respective activities (Rohacs 
et al., 2008). The most evolutionarily conserved isoform group, PLCδ, is most poorly understood 
and not all animal groups have this specific isoform (Rebecchi & Pentyala, 2000; Irino et al., 2004; 
Rohacs et al., 2008). The regulation of the PLCδ isoforms is still under investigation and activation 
requires increased [Ca2+]i (Allen et al., 1997; Rohacs et al., 2008). It is known that all PLC isoforms 
requires Ca2+ but the PLCδs are particularly sensitive to small variations in physiological [Ca2+]i 
(Allen et al., 1997; Rohacs et al., 2008). The second group of PLC isoforms include PLCβ, which 
are activated by GPCRs via activation of Gβγ or Gqα subunits (Rebecchi & Pentyala, 2000; Rohacs 
et al., 2008). Many hormones and bioactive molecules such as VP, bradykinin and acetylcholine 
act via this pathway to activate PLCβ1-4 isoforms (Rebecchi & Pentyala, 2000; Rohacs et al., 2008). 
Finally the PLCγ isoforms are activated by receptor tyrosine kinases, which are receptors for 
hormones such as insulin and nerve growth factor (Rebecchi & Pentyala, 2000; Rohacs et al., 
2008).  
PIP2 is particularly important in the regulation of voltage-gated K
+ channels (Suh & Hille, 2002; 
Zhang et al., 2003; Suh & Hille, 2005), VGCCs (Hille, 1994; Ikeda, 1996; Wu et al., 2002; Suh & 
Hille, 2005) and TRP channels (Hilgemann et al., 2001; Moran et al., 2004; Brauchi et al., 2007; 
Rohacs, 2007; Rohacs et al., 2008). The original model of the effect of PIP2 on TRPV1 postulated 
that under normal conditions, PIP2 is present on the cell membrane with the TRPV1 channel and 
tonically suppresses its activity (Chuang et al., 2001). During events that result in PLC activation, 
the PIP2 degrades and lifts its tonic suppression of the TRPV1 channel resulting in increased 
TRPV1 activity (Chuang et al., 2001). When PIP2 was added or when antibodies against PIP2 were 
used, the TRPV1 channels were suppressed and potentiated respectively (Chuang et al., 2001). 
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Similar studies investigating the role of PIP2 regulation of other TRPs, such as TRPM5 (Liu & 
Liman, 2003), TRPM7 (Runnels et al., 2002), TRPM8 (Liu & Qin, 2005) and TRPA1 (Corey et 
al., 2004; Hirono et al., 2004), showed that PIP2 has an opposite role, and results in activation of 
these channels (Rohacs et al., 2008). However, other studies on TRPV1 channels showed that in 
excised membrane patches, PIP2 actually potentiates TRPV1 (Stein et al., 2006; Zhang & 
McNaughton, 2006; Lukacs et al., 2007). This finding was later confirmed in the same excised 
patch preparation and showed that the inhibitory or activation response depends upon the 
concentration of TRPV1 agonists such as capsaicin (Lukacs et al., 2007). Similar inconsistencies 
of other TRP channels have documented the dual modulatory role of PIP2 on TRPA1 (Bautista et 
al., 2006; Kwan et al., 2006) and TRPC channels (Putney Jr, 2007).  
Muscarinic GPCRs acting via PLC-mediated degradation of PIP2 cause a decrease in the M-type 
K+ current (Suh & Hille, 2002; Zhang et al., 2003; Ford et al., 2004). This increases neuronal 
excitability by muscarinic activation of PLC, showing that PIP2 has an activating role for those K
+ 
channels (Zhang et al., 2003; Ford et al., 2004). The decrease in the M-current took about 10 
seconds and recovered after 100-200 seconds, which is about the time it takes to degrade PIP2 and 
resynthesize it, respectively (Suh et al., 2004). The direct addition of PIP2 was shown to activate 
these K+ channels (Zhang et al., 2003; Ford et al., 2004).  
1.2.2 Long-term adaptations 
 
 
Under chronic conditions of osmotic stress, the MNCs can undergo certain adaptations that allow 
them to sustain hormonal output (Hatton, 1997). The adaptations seen in MNCs fall under two 
broad categories, structural and functional (Hatton, 1997). These adaptive processes are recruited 
during the stress and are sustained for up to hours or days, but are reversed when the conditions 
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return to normal (Hatton, 1997). Current understandings and recent insights into this remarkable 
plasticity seen in MNCs will be further examined.  
1.2.2.1 Structural adaptations 
The MNCs and astrocytes of the SON undergo structural changes that may contribute to sustained 
hormonal output during chronic hypertonic conditions (Hatton, 1997). Normally, only one percent 
of the MNC membranes are in contact with other MNCs and the mean distance between them is 
about 10 nm (Tweedle & Hatton, 1977; Modney & Hatton, 1989; Marzban et al., 1992). When the 
rat is dehydrated overnight, the MNC intercellular contact increases 10 times, which is reversible 
after rehydration (Tweedle & Hatton, 1976, 1977; Gregory et al., 1980). In more extreme cases 
such as drinking hypertonic saline and dehydration lasting several days (7-10 days), results show 
that there exists a proportional relationship between amount of hyperosmotic stress and amount of 
glial withdrawal and soma hypertrophy (Modney & Hatton, 1989; Marzban et al., 1992; Theodosis 
& Poulain, 1993). When hypertonic infusions are utilized, the glial retraction can be visualized 
after 5 hours (Beagley & Hatton, 1992; Hatton, 1997, 2002) and even after 30 minutes if infused 
transcardially (Tweedle et al., 1993). Under hypotonic conditions, the amino acid taurine is 
released from the glia, which inhibits MNC firing and lowers VP output resulting in diuresis 
(Hussy et al., 1997; Deleuze et al., 1998; Deleuze et al., 2005). The somatic area is shown to 
increase about 170% in electron micrographs of rat SONs subject to 10 day dehydration with 
salinized drinking water (Modney & Hatton, 1989). Capacitance measurements to measure 
changes in membrane surface area have confirmed a 33% increase in dehydrated rats with salinized 
drinking water (Tanaka et al., 1999). In our lab, acutely isolated MNCs exposed to hypertonic 
solution for 90 minutes had a 7% increase in whole-cell capacitance (Shah et al., 2014).  
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Due to the differences in hormonal output of the two types of MNCs, different stressors trigger 
different responses between both types (Bourque et al., 1994; Bourque & Oliet, 1997; Bourque, 
1999, 2008). During long term hypertonic stress, both VP and OT MNCs undergo the 
aforementioned changes, while pregnant rats undergoing lactation and parturition show the 
described structural changes only in OT MNCs (Hussy, 2002). A study documenting the effect of 
chronic hypotonicity on MNC structure has shown MNC shrinkage (Zhang et al., 2001). The study 
investigated the cell and nuclear sizes of SON neurons and found that under chronic hypotonic 
conditions (about 223 mosmol/kg) for 7 days resulted in a 40% decrease in both cell soma and 
nuclear size (Zhang et al., 2001). Thus the MNCs are structurally adaptable to both hypertonic and 
hypotonic osmotic stresses (Hatton, 1997).  
1.2.2.2 Functional adaptations 
Other changes in MNCs include the upregulation of specific ion channels and receptors on the cell 
membrane and also various genes to help MNCs to metabolically adapt in the long term (Glasgow 
et al., 2000; Burbach et al., 2001; Yue et al., 2006). These functional changes, including changes 
in membrane and cytosolic proteins, are thought to lower electrical thresholds of the MNCs to 
facilitate phasic firing (Glasgow et al., 2000; Burbach et al., 2001; Yue et al., 2006). These changes 
eventually result in changes in the cell activity and electrical firing patterns that help to sustain 
hormonal output (Hatton, 1997). The following sections will address some of the changes seen 
membrane and cytosolic proteins during chronic dehydration states.  
1.2.2.3 Changes in cell surface levels of channels and receptors 
During chronic conditions of hypertonicity, MNCs undergo a functional adaptation, including 
upregulation of many cell membrane channels and receptors (Shuster et al., 1999; Tanaka et al., 
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1999; Hurbin et al., 2002; Tobin et al., 2011). VP production and release is increased in response 
to chronic hypertonicity and this also causes autoreceptors in the SON to adjust to the increased 
VP output (Bourque, 2008). In a rat model, the mRNA of V1a receptors decreased with increased 
water load and in opposition, during dehydration, the V1a receptor levels were higher (Hurbin et 
al., 2002). This co-expression of VP and its autoreceptor V1a means that the nuclear pathways 
resulting in their synchronized regulation are similar or interconnected (Hurbin et al., 2002). Given 
that antagonizing V1a receptors leads to phasic firing, the increase in V1a can be functionally 
relevant to modulate MNC electrical firing during high VP release (Hurbin et al., 2002). 
In another study, rats were salt-loaded and it was observed that the mRNA of α-II, Na6, β1 and β2 
Na+ subunits were increased (Tanaka et al., 1999). In addition, immunofluorescence studies 
showed enhanced levels of Na+ channels with electrophysiological confirmation of increased Na+ 
transients and enhanced amplitude and density of persistent Na+ currents (Tanaka et al., 1999). 
Thus MNCs, in addition to increasing electrical activity through activation of Na+ channels, have 
the adaptive ability to synthesize and translocate Na+ channels to the plasma membrane and change 
its intrinsic electrical properties (Tanaka et al., 1999).  
Somatodendritic release in MNCs is a very dynamic process and involves other peptides co-
released with VP to help ensure regulation of hormone output (Shuster et al., 1999; Brown & 
Bourque, 2004, 2006). It is shown that salt-loading causes an increase in VP release that was 
concomitant with a rise in κ-opioid receptors at the plasma membrane (Shuster et al., 1999). More 
specifically, immunofluorescence studies showed that the ratio between κ-opioid receptor 1 
(κOR1) in the plasma membrane and in vesicles containing neuropeptides significantly increased 
with hypertonic stimulus (Shuster et al., 1999). Dynorphin is released with VP and decreases Ca2+ 
influx and neuropeptide release (Brown & Bourque, 2004, 2006). Thus the co-release of dynorphin 
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along with an increase in κOR1 on the plasma membrane results in an increase in autocrine-like 
regulation and decrease in VP and OT release (Shuster et al., 1999; Brown & Bourque, 2004, 
2006).    
 
1.2.2.4 Changes in cellular protein expression  
 
During conditions of chronic osmotic stress, the MNCs undergo specific proteomic changes 
(Glasgow et al., 2000; Burbach et al., 2001; Yue et al., 2006). The studies documenting the effects 
of gene upregulation in hypertonic treated rats show that 37 genes are upregulated from hypertonic 
treated rats compared to hypotonic treated rats (Glasgow et al., 2000). Some of the over-expressed 
genes include so-called “housekeeping” genes, which are involved in various cellular processes 
such as energy metabolism and cell homeostasis (Glasgow et al., 2000). The Na+/K+-ATPase is 
one such protein that is upregulated and is involved in three main processes, maintenance of resting 
membrane potential, driver of secondary active transport and maintenance of cell volume 
(Geering, 1997). Another common protein found in the mitochondria, the cytochrome-c oxidase 
is also upregulated, which suggests that the cell is preparing for increased protein expression by 
increasing the mitochondrial energy production capacity (Krukoff et al., 1983; Wong-Riley, 1989; 
Glasgow et al., 2000). This study also documented the increase in expression of PEP-19, which is 
a calmodulin-binding protein (Glasgow et al., 2000). Increased expression of PEP-19 is thought 
to decrease the amount of Ca2+-mediated and calmodulin associated cellular pathways (Gainer & 
Wray, 1994; Glasgow et al., 2000). Thus in chronic osmotic stress events the increase in [Ca2+]i 





1.2.2.5 Translocation of channels and receptors in other neurons 
 
 
Exocytosis involves fusion of smaller vesicles within the cell to the plasma membrane to release 
its inner contents, which may include hormones, neurotransmitters or small bioactive molecules 
(Morgan, 1995). During release of the hormones or neurotransmitters in neurons, the action 
potentials generated cause activation of VGCCs which allows Ca2+ influx, exocytotic fusion of the 
neuropeptide vesicles and release into the extracellular space (Hatton, 1990; Armstrong, 1995). 
There also exists a fusion machinery that allows interaction, docking and fusion of the synaptic 
vesicles with the plasma membrane (Pryer et al., 1992; Rothman, 1994; Sudhof, 1995).  
Constitutive exocytosis is an unregulated pathway that cells use for delivery to the cell membrane 
for constant extracellular release (Morgan, 1995; Gerber & Südhof, 2002), while regulated 
exocytosis involves intracellular control of the plasma membrane fusion events, mainly executed 
by secretory cells and neurons (Burgoyne & Morgan, 1993). Regulated exocytosis can involve 
translocation, a transfer of receptors and channels to the cell surface that can change the cellular 
activity (Chieregatti & Meldolesi, 2005). In kidneys, AQP2 is translocated to the plasma 
membrane through VP-mediated action on the V2 receptor (Agre, 2006; Petersen, 2006; Ball, 
2007). A classical neuronal example occurs during learning and memory with the receptors 
involved in the synaptic plasticity of hippocampal neurons (Malinow & Malenka, 2002). Long 
term potentiation (LTP) in these cells involves insertion of GluR1, the subunit of the α-amino-3-
hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) (Malinow & Malenka, 2002). 
This translocation of the GluR1 subunit involves increased [Ca2+]i, calmodulin and vesicle-
associated membrane protein-2 (VAMP2), a controller of regulated exocytosis (Hayashi et al., 
2000; Lu et al., 2001). In OT MNCs, using thapsigargin to increase [Ca2+]i, resulted in an increase 
in N-type Ca2+ current which is thought to be due to translocation of the N-type Ca2+ channels to 
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the plasma membrane (Tobin et al., 2011). Other receptors that are translocated upon exogenous 
stimulation include γ-aminobutyric acid-A (GABAA) (Wan et al., 1997) and NMDARs (Lan et 
al., 2001). Stimulation with growth factors can cause rapid translocation of TRPC5 and TRPC3 
channels in neurons (Clapham, 2003; Bezzerides et al., 2004; Singh et al., 2004). Thus the 
phenomenon of translocation in neurons has an effect to aid functional adaptations to facilitate 
events such as synaptic plasticity, electrical excitability, sensitivity to exogenous mediators and 
axonal growth (Burgoyne & Morgan, 1993; Chieregatti & Meldolesi, 2005; Cocucci et al., 2006). 
The translocation of channels and receptors is a dynamic process and can involve reuptake during 
conditions when those receptors and channels aren’t required (Vieira et al., 1996; Carroll et al., 
2001). This is referred to endocytosis, which requires a separate set of molecular machinery 
(Goldstein et al., 1979; Pastan & Willingham, 1985). Vesicles are formed by a class of coat 
proteins called clathrin that forms invaginations at the plasma membrane with the assistance of 
several proteins involved in the endocytosis process (Le Roy & Wrana, 2005; McMahon & 
Boucrot, 2011). A final protein known as dynamin, via hydrolysis of guanosine-5'-triphosphate 
(GTP), is required for the final pinching off of the invaginations and formation of the vesicle 
(Boron & Boulpaep, 2008; Morlot & Roux, 2013). 
1.2.2.6 PKC involvement in translocation 
 
Regulated exocytosis involves the same basic mechanisms for vesicular fusion as constitutive 
exocytosis, but the process also includes other proteins involved in fine-tuning the temporal and 
spatial control of these events (Morgan et al., 2005). Many studies have documented protein kinase 
A and PKC in the regulated exocytosis of secretory and neuronal cells (Lindau & Gomperts, 1991; 
Hille et al., 1999; Turner et al., 1999; Leenders & Sheng, 2005). PKC requires the combination of 
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phosphatidylserine, DAG and Ca2+ for maximal activity, and is differentiated into isoenzyme 
families based on their specific requirements for activity (Newton, 2001). The role of PKC in 
exocytosis was discovered by observations that phorbol esters (analogues of DAG) stimulated 
secretion from cells (Terbush & Holz, 1990). The DAG was confirmed to act via PKC, as co-
administering PKC inhibitors with phorbol esters negated the enhanced secretory response 
(Terbush & Holz, 1990). A study that added purified PKC enzyme in permeabilized chromaffin 
cells saw increased exocytosis, showing PKC is regulating the exocytotic machinery with Ca2+ as 
a cofactor (Naor et al., 1989; Morgan & Burgoyne, 1992).  
The role of PKC in the functional adaptation of cells has been well documented and strengthens 
its role as a mediator of non-secretory exocytosis. It has been shown that stimulation of PKC in 
Aplysia bag cell neurons causes an increase in Ca2+ currents and that the mechanism includes 
translocation of specific Ca2+ channels (Strong et al., 1987). In an oocyte expression system, 
exogenous activation of PKC resulted in a fast translocation of TRPV1 channels to the plasma 
membrane (Morenilla-Palao et al., 2004). This rapid increase of TRPV1 on the plasma membrane 
was blocked with botulinum neurotoxin A showing that the phenomenon is indeed a translocation 
event occurring through soluble N-ethylmaleimide sensitive fusion (NSF) attachment protein 
receptor (SNARE)-mediated exocytosis (Morenilla-Palao et al., 2004). Taken together, these data 
show that PKC can cause translocation of ion channels and receptors, which ultimately leads to 
changes in cellular phenotype (Strong et al., 1987; Naor et al., 1989; Terbush & Holz, 1990; 
Morgan & Burgoyne, 1992; Newton, 2001; Morenilla-Palao et al., 2004; Morgan et al., 2005). 
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1.3 Recent findings from the lab 
Our lab focuses on the structural and electrophysiological adaptations of MNCs under chronic 
hypertonic stress. Using biochemical and electrophysiological assays we are attempting to 
determine the mechanism to understand how the MNCs adapt. This section will review some of 
our most recent observations and our current and future directions.  
The cellular events underlying the MNC hypertrophy are difficult to elucidate in the above 
mentioned in vivo models. Our lab has recently developed an in vitro model to use various 
pharmacological and electrophysiological tools to assess and better understand the hypertrophy 
(Shah et al., 2014). I will now briefly mention some of the findings from previous members of the 
lab.  
When acutely isolated MNCs are subject to a 30 mosmol/kg increase in hypertonicity, they 
undergo shrinkage (as most cell types do) but over the course of 150 minutes undergo hypertrophy 
to about 105% of their control size (Shah et al., 2014). This hypertrophy effect is reversible and 
does not occur in hippocampal neurons (Shah et al., 2014). To investigate cellular activities 
involved in hypertrophy various pharmacological tools were utilized. Hypertrophy can be blocked 
by pre-treatment with tetrodotoxin (TTX), SIC channel blocker (SB366791), nifedipine and 
BAPTA-AM (Shah et al., 2014). These results suggest that hypertrophy is dependent upon action 
potentials, SIC activity, increased [Ca2+]i, and Ca
2+ influx through L-type Ca2+ channels (Shah et 
al., 2014). The hypertrophy effect can also be reversed by addition of TTX, SB366791 and 
nifedipine suggesting its maintenance depends on continued electrical activity and sustained Ca2+ 
entry (Shah et al., 2014). The mechanism of cell enlargement is thought to be through insertion of 
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new plasma membrane by exocytotic fusion because a blocker of SNARE-dependent exocytotic 
fusion prevents the hypertrophy (Shah et al., 2014).  
 
It was shown in our lab recently that osmotic stimuli (increases in external osmolality) leads to an 
activation of PLC and subsequent decreases in PIP2 (Shah et al., 2014). Under control conditions, 
it was seen that acutely isolated MNCs have a strong and membrane-selective immunoreactivity 
(Shah et al., 2014). A five minute exposure to 325 mosmol/kg saline resulted in an approximately 
30% decrease in membrane PIP2 immunoreactivity (Shah et al., 2014). Further, preincubation of 
the cells with a PLC inhibitor prevented osmotically-induced changes to PIP2 immunoreactivity. 
Adding a muscarinic receptor agonist (resulting in PLC activation) caused a similar decrease in 
PIP2 immunoreactivity that could be blocked by the PLC inhibitor U73122 (Shah et al., 2014). 
This finding shows that short term exposure of MNCs to high osmolality causes osmotic activation 
of PLC, which then reduces levels of PIP2 (Hilgemann et al., 2001; Shah et al., 2014). A very 
similar finding has been seen in green algae, which shows that hyperosmotic stress causes an 
increase in phospholipase D activity within minutes of hypertonic exposure and also depends on 
the size of the increase in osmolality (Munnik et al., 2000a). Both of these findings are seen in our 
in vitro rat MNC model documenting changes in PLC activity (Shah et al., 2014). 
A rise in [Ca2+]i is the main cue for hormonal and neurotransmitter output from many secretory 
cells such as endocrine cells and neurons respectively. Recent findings from our lab show that 
specifically, L-type Ca2+ currents increase (77%) in the SON of rats that have been deprived of 
water (Zhang et al., 2007a). Radioligand binding assays suggest that rather than a modulation of 
channel function, there is an increase in the abundance of channels on the membrane (32%) 
through translocation of channels from reserves or via increase in protein translation of existing α1 
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subunits (Zhang et al., 2007a). The latter explanation of increased protein translation seems 
plausible as there is no increase in mRNA of L-type Ca2+ subunits (Zhang et al., 2007a). The 
increase in L-type Ca2+ currents may be important in modulating electrical activity through DAP 
and AHP currents (Andrew & Dudek, 1983; Armstrong et al., 1994; Li et al., 1995). Since it is 
known that L-type Ca2+ currents are involved in activating CREB, they may be of importance in 

































CHAPTER 2: HYPOTHESIS AND OBJECTIVES 
 
 
It is difficult to elucidate the mechanism of dehydration-induced MNC hypertrophy using in vivo 
models because of the difficulty in selectively targeting MNCs pharmacologically. Previous 
findings using an in vitro model of acutely isolated MNCs led to the conclusion that osmotically-
evoked hypertrophy to 105% of control size occurs in vitro in response to 325 mosmol kg-1 (Shah 
et al., 2014). The osmotically-evoked hypertrophy involves insertion of new membrane via 
SNARE-mediated exocytotic fusion as evident by a 7% increase in whole-cell capacitance (Shah 
et al., 2014). The initiation and maintenance of hypertrophy depends upon action potentials, SIC 
activation, increased [Ca2+]i and Ca
2+ influx through L-type Ca2+ channels (Shah et al., 2014). 
Finally, MNCs from rats that have been deprived of water show an 80% increase in L-type Ca2+ 
current density and radioligand binding assays show a 32% increase in L-type Ca2+ channel density 
(Zhang et al., 2007a). 
Based on these conclusions we designed the following hypotheses using our in vitro model to 
further study osmotically-induced hypertrophy in acutely isolated MNCs.  
1.) Osmotically-evoked hypertrophy occurs physiologically in a dose-dependent manner, such 
that smaller increases in osmolality result in proportionally smaller amounts of 
hypertrophy. 
2.) Osmotically-evoked hypertrophy occurs independently of cell volume regulatory processes 
and does not depend on activation of NKCC1.  
3.) Reversal of hypertrophy depends upon dynamin-mediated endocytosis. 
4.) Osmotically-evoked hypertrophy depends upon activation of PLC and PKC. 
5.) Hypertrophy can be induced by neuronal depolarization, Ca2+ entry and activation of PKC. 
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6.) Sustained exposure to hypo-osmolar solutions results in a reversible and sustained decrease 
in MNC soma size. 
7.) Sustained exposure to hypertonic solutions will increase immunolabeling of the L-type 
Ca2+ channel CaV1.2 subunit.  
The neurohormonal mechanisms underlying the regulation of extracellular osmolality are of 
critical physiological importance (Bourque, 2008).  These mechanisms act to maintain the 
osmolality of human plasma close to a “set-point” of 290 milliosmoles per kilogram (Bourque, 
2008). The primary hormonal regulator of osmolality is vasopressin (VP), which is released by the 
magnocellular neurosecretory cells (MNCs) of the SON in the hypothalamus as a function of 
plasma osmolality (Bourque et al., 1994; Bourque & Oliet, 1997; Bourque, 2008). The objectives 
of this thesis are to understand the mechanisms involved in osmotically-induced hypertrophy and 
increased expression of L-type Ca2+ channels in MNCs exposed to sustained increases in 
osmolality as seen in the elderly and chronically ill (O'Neill et al., 1990). The proposed project 
will help to elucidate the mechanisms underlying this important example of neuroendocrine 










CHAPTER 3: MATERIALS AND METHODS 
3.1 Chemicals 
All chemicals, unless stated otherwise, were from Sigma-Aldrich Corporation (St. Louis, MO, 
U.S.A.). The membrane dye CellMask™ Orange was purchased from Invitrogen (Carlsbad, CA). 
The primary antibody, CaV1.2 was from Alomone Labs (Jerusalem, Israel). The secondary 
antibodies were Alexa fluor 488 anti-rabbit from Invitrogen (Carlsbad, CA).   
3.2 Animals and cell preparation 
The handling of the animals and the experiments were approved by the University of 
Saskatchewan’s Animal Research Ethics Board and adhered to the Canadian Council on Animal 
Care guidelines for humane animal use.  Male Long Evans rats weighing 250-300 grams were 
given ad libitum food and water and were used in all of the described experiments. The previously 
established MNC isolation protocol (Liu et al., 2005) and the criteria for MNC identification were 
followed (Oliet & Bourque, 1992). Briefly, the rats were placed in a chamber containing halothane 
for anaesthetization and a small animal guillotine was used for decapitation. The skull was opened 
and the brain was hydrated with a PIPES (piperazine-N,N′-bis(2-ethanesulfonic acid)) buffer 
solution composed of (in mM, pH 7.10): NaCl, 110; KCl, 5; MgCl2, 1; CaCl2, 1; PIPES, 20 and 
glucose, 25 (abbreviated as PGC). The osmolality of the isotonic PGC was maintained at 295 ± 3 
mosmol kg-1 with a VAPRO vapor pressure osmometer (Wescor, Logan, UT, U.S.A.). The 
hypertonic osmolalities were obtained by adding mannitol to isotonic PGC. Hypotonic PGC (280 
mosmol kg-1) was made by adding 10 mM glucose (instead of 25 mM) to PIPES. Upon hydration, 
an approximately 1.0 mm thick coronal slice of the brain was removed that contained most of the 
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SON and pinned to a petri dish submerged in isotonic PGC. Tissue blocks containing SON were 
excised and placed in isotonic PGC containing trypsin from bovine pancreas type XI, 0.6 mg/mL), 
bubbled with 100% O2 in a water bath maintained at 34°C for 90 minutes. The tissue blocks were 
then transferred to non-trypsinized PGC, and were bubbled with 100% O2 at room temperature for 
30 minutes. The blocks were then mechanically dispersed by trituration using fire-polished Pasteur 
glass pipettes with graded decreases in opening diameter. The triturated MNCs were plated onto 
glass bottom culture dishes, covered to avoid evaporation, and allowed to adhere to the glass for 
30 minutes at room temperature before initiating experiments.  
3.3 Morphometry experiments 
Acutely isolated MNCs were mounted onto the microscope stage and oxygenated PIPES solutions 
of various osmolalities were perfused into the plate using a gravity perfusion system. In some 
experiments, MNCs were exposed to stationary baths (no perfusion) of specific osmolalities, with 
or without chemicals, as indicated in the text. On average, there were 2-3 MNCs per frame of view 
in each experiment. The MNCs were photographed with a cooled charge-coupled device (CCD) 
camera attached to a Zeiss Axiovert 200 microscope with a 40x objective at various indicated 
times throughout the experiments. The maximal circumference of the cell soma was traced and the 
cross-sectional area (CSA) was determined using ImageJ (National Institutes of Health). The data 
was normalized by dividing the CSA of each image with the average CSA of the same cell under 
control conditions while in isotonic PGC and are represented as mean ± standard error of mean 
(SEM). Only the cells that showed a hypertrophy response (shrinkage, enlargement and recovery 
of cell soma) were used in forming the graphs. Cells which did not recover back to their control 
CSA were deemed unhealthy and so were excluded.  
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3.4 Fluorescence images of hypertrophy 
Acutely isolated MNCs were stained with the plasma-membrane specific stain, CellMask™ 
Orange (Invitrogen). Briefly, after plating the MNCs and allowing them to adhere, the cells were 
incubated with 5 µg/mL CellMask™ Orange for 5 minutes and subsequently rinsed with isotonic 
saline three times. The cells were imaged with appropriate filter sets first in isotonic saline for 
control images and then treated with hypertonic saline for subsequent images at 5 and 80 minutes. 
3.5 Immunocytochemistry of CaV1.2 subunit 
Acutely isolated MNCs were exposed to isotonic PGC, hypertonic PGC or hypertonic PGC + TTX 
(1 µM) for 120 minutes after which they were washed three times with phosphate buffered saline 
(PBS). The MNCs were then washed three times with 10% formalin solution for 20 minutes at 
room temperature. Subsequently the cells were washed three times with PBS. The MNCs were 
then treated with blocking solution (10% donkey serum with Triton-X in PBS) for one hour at 
room temperature. The MNCs were then incubated with primary antibodies from Alomone Labs 
against the L-type Ca2+ subunit CaV1.2 (1:500) at 4°C overnight. The negative controls used in the 
experiments were not incubated with primary antibody. The following morning, the MNCs were 
washed three times with PBS and incubated in the secondary antibody, Alexa fluor 488 donkey 
anti-rabbit (1:2000) from Invitrogen. The MNCs were given a final three washes. The mounting 
solution, Citifluor, was added to the wells of each plate and the cells were viewed with a Zeiss 
Axiovert 200 inverted microscope with a 40x objective with differential image contrast (DIC) and 
fluorescence image filter sets. The images were captured using a CCD camera and ImageJ software 
was used to measure the mean fluorescence intensity by drawing a perimeter around the cell soma. 
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The data was normalized to the mean fluorescent intensity of all cells treated with isotonic PGC 
on the same day and represented as mean fluorescence ± SEM.  
3.6 Data analysis 
The data was entered into GraphPad Prism® and various statistical tests were used, as indicated, 
to determine statistical significance. All results are shown as mean ± SEM. A statistical test 














CHAPTER 4: RESULTS 
4.1 Osmotically-evoked hypertrophy occurs at physiological osmolalities in a dose-dependent 
manner 
Previous members of the lab have shown that MNCs exposed to hypertonic solution display an 
immediate shrinkage but undergo reversible hypertrophy over the course of 150 minutes (Shah et 
al., 2014). We wanted to see if hypertrophy can occur at more physiological increases of 
hypertonicity and thus see if the effect size is osmolality-dependent. Acutely isolated MNCs were 
perfused with 100% oxygenated isotonic PGC (295 mosmol kg-1) for 10 minutes to record the 
basal control CSA. The MNCs (n=12; 4 experiments) were then subsequently perfused with 
hypertonic saline (325 mosmol kg-1) and the CSA was monitored at various time points. Figure 
4.1 represents an MNC fluorescently labeled with a membrane-selective dye (CellMask) 
undergoing both shrinkage (at 5 minutes) and hypertrophy (80 minutes). The red line is the control 
CSA and represents shrinkage (red line encircling the cell perimeter) and hypertrophy (red line 
smaller than cell perimeter). As shown in Figure 4.2, the MNCs shrunk to a CSA of 94.5 ± 0.8% 
of control (a mean CSA reduction from 363.4 ± 36.3 µm2 to 343.4 ± 35.4 µm2) after 5 minutes and 
after about 20 minutes started to hypertrophy and peaked in size at 105.2 ± 0.7% (381.7 ± 38.2 
µm2) after about 60 minutes. The mean shrunken and enlarged CSA (measured at 5 and 60 minutes, 
respectively), were significantly different than the mean CSA of the control (using a one-way 
repeated measures analysis of variance test; P < 0.01 in both cases). The amount of hypertonicity 
was reduced to see if osmotically-evoked hypertrophy occurs at more physiological hypertonic 
osmolalities. When the MNCs were exposed to an osmolality of 305 mosmol kg-1 (n=10; 2 
experiments) the cells (from a baseline mean CSA of 357.2 ± 30.1 µm2) had reduced levels of 
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shrinkage (348.7 ± 28.9 µm2; 97.6 ± 0.4%) and hypertrophy (368.1 ± 29.9 µm2; 103.1 ± 0.4%). 
When the MNCs were exposed to an osmolality of 300 mosmol kg-1 (n=10; 2 experiments) the 
cells has a baseline mean CSA of 324.9 ± 25 µm2 and had even lesser levels of shrinkage (319.5 
± 25 µm2; 98.2 ± 0.4%) and hypertrophy (328.4 ± 25.2 µm2; 101.1 ± 0.2%). Each of the shrunken 
and enlarged CSAs of the MNCs from both lower hypertonic treatments (300 and 305 mosmol kg-
1) were significantly different than their control CSA using a one-way analysis of variance test (P 
< 0.01). In all hypertonic treatments, when the MNCs were returned to the control isotonic PGC, 
they rapidly returned to their control CSA after about 5-10 minutes. A control experiment 
involving MNCs (n=5; 1 experiment) perfused with isotonic PGC (295 mosmol kg-1) throughout 
the experiment showed that there is no change in MNC soma size. The mean CSA of the shrunken 
and hypertrophied states of all three hypertonic treatments was shown to be statistically different 
than the mean CSA of MNCs treated with isotonic PGC at the same time periods (using a two-
way analysis of variance; P < 0.01 in all cases). The amount of shrinkage seen in the hypertonic 
treated MNCs is comparable to the predicated amount of shrinkage in response to a short-term 
hypertonic shock (Zhang & Bourque, 2003). The results suggest that MNC hypertrophy is 
osmotically-evoked and dependent upon the degree of osmolality change with the ability to reverse 











Figure 4.1: Fluorescence images of a MNC undergoing shrinkage and hypertrophy. The 
image on the left shows a DIC image of an isolated MNC in isotonic PGC. The other images 
shows the same MNC stained with a membrane dye (CellMask) at 5 minutes (middle) and 80 
minutes (right) after exposure to hypertonic PGC. The red line shows the cellular perimeter 
under isotonic conditions for comparison. The perimeter of the cell in the middle is smaller than 


































Figure 4.2: Increases in osmolality evoke reversible hypertrophy in osmosensitive MNCs of 
the SON in a dose-dependent manner. Perfusion of oxygenated hypertonic PGC (325, 305 and 
300 mosmol kg-1) causes acutely isolated MNCs to shrink and hypertrophy over 90 minutes (n=12, 
10 and 10, respectively), while perfusion of isotonic PGC (295 mosmol kg-1) results in no change 
in cell size. Returning the MNCs to isotonic PGC results in a rapid reversal of hypertrophy to the 
original control CSA. The period of hypertonic PGC perfusion is indicated by the grey bar at the 




4.2 Osmotically-evoked hypertrophy occurs independently of NKCC1-mediated cell volume 
regulatory processes 
We wanted to test whether hypertrophy requires activation of the Na+/K+/2Cl- co-transporter 
NKCC1, which is commonly involved in cell volume regulatory processes (O'Neill & Klein, 1992; 
Nardou et al., 2009). Acutely isolated MNCs were treated with hypertonic PGC in a stationary 
bath with the addition of bumetanide (10 µM), an antagonist of the NKCC1. Bumetanide at 10 μM 
is known to block NKCC1 effectively without affecting other membrane ionic transporters such 
as or Cl-/HCO3
- and Na+/H+ exchangers or the K-Cl cotransporter KCC2 (O'Grady et al., 1987; 
Gillen et al., 1996; Tyzio et al., 2006).  The cells were first incubated in isotonic PGC for 10 
minutes followed by switching the stationary bath to 325 mosmol kg-1 hypertonic PGC with 
bumetanide. The MNCs CSA was monitored at various time points. As shown in Figure 4.3, the 
MNCs treated with bumetanide (n=10; 3 experiments) shrunk to a CSA of 94.4 ± 0.7% of control 
after 5 minutes and hypertrophied to a maximum CSA of 105.2 ± 0.7% after 75 minutes. The mean 
shrunken and enlarged CSA of bumetanide-treated cells (measured at 5 and 75 minutes, 
respectively), were significantly different than the mean CSA of the control (using a one-way 
repeated measures analysis of variance test; P < 0.01 in both cases). The mean CSA of the shrunken 
and hypertrophied states of the bumetanide-treated MNCs in hypertonic PGC were not statistically 
different than the mean CSA of MNCs treated with hypertonic PGC without bumetanide at the 
same time periods (using a two-way analysis of variance; P > 0.05 in both cases). When the MNCs 
were returned to the control isotonic PGC following hypertonic treatment with or without 
bumetanide, they rapidly returned to their control CSA after about 5-10 minutes. The hypertrophic 
response did not appear to be affected by the addition of bumetanide, suggesting NKCC1-mediated 





Figure 4.3: Osmotically-evoked hypertrophy does not require activation of NKCC1. The 
shrinkage and hypertrophy response of MNCs (n=10) to hypertonic saline (325 mosmol kg-1) was 
+-K+-Cl- co-
transporter NKCC1.  The response of the MNCs (n=12) to perfusion of hypertonic saline (325 
mosmol kg-1) without bumetanide is shown for comparison. Returning the MNCs to isotonic PGC 
results in a rapid reversal of hypertrophy to the original control CSA in both groups. The period 






4.3 Reversal of hypertrophy depends upon dynamin-mediated endocytosis 
We wanted to examine the role of dynamin-dependent endocytosis in the reversal of MNC 
hypertrophy. Acutely isolated MNCs were perfused with hypertonic PGC and they were incubated 
with dynasore (80 µM), an inhibitor of dynamin-dependent endocytosis (Macia et al., 2006; 
Kirchhausen et al., 2008) prior to recovering the cells with isotonic PGC. The cells were first 
incubated in isotonic PGC for 10 minutes followed by perfusion with 325 mosmol kg-1 hypertonic 
PGC. The MNCs CSA was monitored at various time points. As shown in Figure 4.4, the MNCs 
treated with dynasore (n=10; 3 experiments) shrunk to a CSA of 94.7 ± 0.5% of control after 5 
minutes and hypertrophied to a maximum CSA of 104.9 ± 1% after 85 minutes. The mean 
shrunken and enlarged CSA of dynasore-treated cells (measured at 5 and 85 minutes, respectively), 
were significantly different than the mean CSA of the control (using a one-way repeated measures 
analysis of variance test; P < 0.01 in both cases).  However, the mean CSA of the MNCs after 
adding isotonic PGC for recovery was statistically different than the mean CSA of the control 
(using a one-way repeated measures analysis of variance test; P < 0.01). In addition, the mean CSA 
of the MNCs after adding isotonic PGC for recovery was not statistically different than the mean 
CSA of the maximal hypertrophied state (using a one-way analysis of variance test; P > 0.05). The 
results suggest that the hypertrophic response was unaffected by the addition of dynasore. 
However the MNCs were not able to recover following addition of isotonic PGC. The recovery of 





Figure 4.4: Reversal of osmotically-evoked hypertrophy depends on dynamin-dependent 
endocytosis. The shrinkage and hypertrophy response of MNCs (n=10) to hypertonic saline (325 
mosmol kg-1) was not affected by the presence of dynasore (80 µM), which is an inhibitor of 
dynamin-dependent endocytosis.  The mean CSA of MNCs after perfusion with isotonic PGC was 
statistically different than the control CSA, but not statistically different than the maximal 
hypertrophied state. The period of hypertonic PGC exposure is indicated by the grey bar on the 





4.4 The activation of PLC and PKC are requirements for osmotically-evoked hypertrophy 
The role of PLC and PKC in translocation of channel and receptors have been studied in both 
neuronal and non-neuronal cells (Strong et al., 1987; Van Epps-Fung et al., 1997; Lin et al., 2002; 
Morenilla-Palao et al., 2004). We wanted to see whether the activation of PLC or PKC is required 
to undergo hypertrophy in MNCs. Acutely isolated MNCs were exposed to hypertonic PGC in the 
presence of an inhibitor of PLC (U73122; 1 µM) or PKC (bisindolylmaleimide I; 1 µM) to 
understand whether activation of either one or both enzymes is required for osmotically-evoked 
hypertrophy. The cells were first incubated in isotonic PGC for 5 minutes followed by addition of 
325 mosmol kg-1 hypertonic PGC with either enzyme inhibitor. The MNCs CSA was monitored 
at various time points. As shown in Figure 4.5, the MNCs treated with the PLC inhibitor (n=12; 4 
experiments) shrunk to a CSA of 94.1 ± 0.4% of control and remained in the shrunken state, which 
was statistically different than the mean CSA of the control (using a one-way analysis of variance 
test; P < 0.01). The MNCs treated with the PKC inhibitor (n=12; 5 experiments) shrunk to a CSA 
of 95.1 ± 0.3% of control and remained in the shrunken state, which was statistically different than 
the mean CSA of the control (using a one-way analysis of variance test; P < 0.01). When both 
treatment groups were re-exposed to isotonic PGC, the MNCs rapidly recovered to their respective 
control size and their CSAs were not statistically different than the control CSAs (using a one-way 
analysis of variance test; P > 0.05 for both treatments). The results show the hypertrophic response 
was prevented by inhibitors of both PLC and PKC suggesting osmotically-evoked hypertrophy 




Figure 4.5: Osmotically-evoked hypertrophy involves activation of PLC and PKC. When 
MNCs are exposed to hypertonic PGC (325 mosmol kg-1) in the presence of a PLC inhibitor 
(U73122) (n=12) or a PKC inhibitor (bisindolylmaleimide I) (n=12) they show the acute osmotic 
shrinkage response and remain shrunk over the measured time period. Upon re-exposure to 
isotonic PGC, they rapidly recover to their control CSA. The period of hypertonic PGC exposure 












4.5 Hypertrophy can be induced by activating PKC 
As shown previously, hypertrophy was prevented in MNCs exposed to a PKC inhibitor. We 
wanted to test whether activation of PKC is sufficient to cause hypertrophy. Acutely isolated 
MNCs were exposed to isotonic PGC with a PKC activator (phorbol 12-myristate 13-acetate 
(PMA); 0.1 µM). The cells were first incubated in isotonic PGC for 5 minutes followed by addition 
of isotonic PGC with the PKC activator. The MNCs CSA was monitored at various time points. 
As shown in Figure 4.6, the MNCs treated with the PKC activator (n=7; 4 experiments) enlarged 
to a maximum CSA of 102.9 ± 0.3% of control and remained in the enlarged state, which was 
statistically different than the mean CSA of the control (using a one-way analysis of variance test; 
P < 0.01). When the PKC activator treated MNCs were re-exposed to normal isotonic PGC, the 
MNCs rapidly recovered to their respective control sizes and their CSAs were not statistically 
different than the control CSAs (using a one-way analysis of variance test; P > 0.05). A separate 
experiment was conducted to see if this a true effect of the activator by treating the MNCs with an 
inactive analogue of the PKC activator ( -phorbol 12-myristate 13-acetate; 0.1 µM). The MNCs 
treated with the inactive analogue of the PKC activator (n=5; 2 experiments) did not hypertrophy 
and their mean CSAs were not statistically different at each time point throughout the experiment 
(using a one-way analysis of variance test; P > 0.05). The results suggest that hypertrophy seems 





















Figure 4.6: Hypertrophy can be induced by activation of PKC. When MNCs are exposed to 
isotonic PGC with PMA (0.1 µM) (n=7) they hypertrophy within 5 minutes and remain enlarged 
over the course of the exposed time period. When MNCs are exposed to isotonic PGC with an 
inactive analogue of PMA (0.1 µM) (n=5) they do not show hypertrophy and remain at the control 
size. Upon re-exposure to normal isotonic PGC, the PMA-treated MNCs rapidly recover to their 





295 mosmol kg-1 + PKC activator 




4.6 Hypertrophy can be activated by depolarization of the MNCs 
Previous lab members have shown that exposing MNCs to TTX in hypertonic PGC prevented 
hypertrophy, suggesting action potential firing is required for hypertrophy (Shah et al., 2014). We 
wanted to test whether exposing the MNCs to depolarizing isotonic PGC is sufficient to induce 
hypertrophy. Acutely isolated MNCs were exposed to isotonic PGC in high [K+] conditions (25 
mM KCl) to depolarize the cells. Using the Goldman-Hodgkin-Katz Equation, it was calculated 
that the increase in extracellular K+ results in the MNCs depolarizing to about -40 millivolts (mV), 
which can cause action potential firing (Boron & Boulpaep, 2008) or open low voltage-gated 
CaV1.3 Ca
2+ channels (Fisher & Bourque, 1995, 1996). The MNCs were first incubated in isotonic 
PGC for 5 minutes followed by addition of isotonic PGC with high [K+]. The MNCs CSA was 
monitored at various time points. As shown in Figure 4.7, the MNCs treated with the high K+ 
conditions (n=5; 2 experiments) enlarged to a maximum CSA of 103.9 ± 0.4% of control and 
remained in the enlarged state which was statistically different than the mean CSA of the control 
(using a one-way analysis of variance test; P < 0.01). When the high K+ treated MNCs were re-
exposed to normal isotonic PGC, the MNCs rapidly recovered to their respective control state and 
their CSAs were not statistically different than the control CSAs (using a one-way analysis of 
variance test; P > 0.05). A separate experiment was conducted to see if this effect can be negated 
by adding a PLC inhibitor (U73122; 1 µM). The MNCs treated with high [K+] isotonic saline with 
PLC inhibitor (n=11; 4 experiments) did not hypertrophy and their mean CSAs were not 
statistically different at each time point throughout the experiment (using a one-way analysis of 
variance test; P > 0.05). The results suggest hypertrophy requires cell depolarization and this effect 





Figure 4.7: Hypertrophy is activated by cell depolarization. When MNCs are exposed to 
isotonic PGC with high [K+] (25 mM) (n=5), they hypertrophy within 5 minutes and remain 
enlarged over the course of the exposed time period. Upon re-exposure to normal isotonic PGC, 
they rapidly recover to their control CSA. When MNCs are exposed to isotonic PGC with high 
[K+] and a PLC inhibitor (n=11), they do not show hypertrophy and remain in the control CSA. 
The period of exposure to high [K+] (with or without PLC inhibitor) is indicated by the grey bar 









4.7 Hypertrophy can be induced by increasing [Ca2+]i 
Previous lab members have shown that exposing MNCs to nifedipine or BAPTA-AM in 
hypertonic PGC, prevented hypertrophy suggesting Ca2+ entry is required for hypertrophy (Shah 
et al., 2014). We wanted to test whether increasing [Ca2+]i is sufficient to induce hypertrophy. 
Acutely isolated MNCs were exposed to isotonic PGC with a Ca2+ ionophore (A231877; 10 µM). 
The cells were first incubated in isotonic PGC for 5 minutes followed by addition of isotonic PGC 
with the Ca2+ ionophore. The MNCs CSA was monitored at various time points. As shown in 
Figure 4.8, the MNCs treated with Ca2+ ionophore (n=9; 4 experiments) enlarged to a maximum 
CSA of 104.5 ± 0.4% of control and remained in the enlarged state, which was statistically 
different than the mean CSA of the control (using a one-way analysis of variance test; P < 0.01). 
When the Ca2+ ionophore-treated MNCs were re-exposed to normal isotonic PGC, the MNCs did 
not recover to their respective control and their CSAs remained statistically different than the 
control CSAs but not statistically different than the hypertrophied states (using a one-way analysis 
of variance test; P < 0.01 and P > 0.05, respectively). The results suggest hypertrophy involves an 





Figure 4.8: Hypertrophy is activated by influx of Ca2+. When MNCs are exposed to isotonic 
PGC with the Ca2+ ionophore, A231877 (10 µM) (n=9) they hypertrophy within 5 minutes and 
remain enlarged over the course of the exposed time period. Upon re-exposure to normal isotonic 
PGC, they do not recover to their control CSA during the 10 minutes monitored. The period of 













4.8 Exposure of MNCs to hypo-osmolar solutions results in a sustained decrease in soma size 
A study investigated the cell and nuclear sizes of SON neurons and found that under chronic 
hypotonic conditions (about 223 mosmol/kg) for 7 days resulted in a 40% decrease in both cell 
soma and nuclear size (Zhang et al., 2001). We therefore tested whether this in vivo finding can 
be replicated in an in vitro model. Acutely isolated MNCs were first incubated in isotonic PGC for 
10 minutes followed by switching the stationary bath to 280 mosmol kg-1 hypotonic PGC. The 
MNCs CSA was monitored at various time points. The MNCs exposed to hypotonic PGC (n=9; 1 
experiment – 2 frames of view) enlarged to a maximum CSA of 103.3 ± 0.3% of control after 10 
minutes and shrunk to a minimum CSA of 97.6 ± 0.3% after 80 minutes. The mean enlarged and 
shrunken CSA of hypotonic PGC treated cells measured at (15 and 85 minutes, respectively), were 
significantly different than the mean CSA of the control (using a one-way repeated measures 
analysis of variance test; P < 0.01 in both cases). The mean CSA of the enlarged and shrunken 
states of the hypotonic PGC treated MNCs were statistically different than the mean CSA of MNCs 
treated with isotonic PGC at the same time periods (using a two-way analysis of variance; P < 0.01 
in both cases). When the hypotonic PGC-treated MNCs were returned to the isotonic PGC, they 
rapidly returned to their control CSA after about 5-10 minutes. The results are shown below in 
Figure 4.9 and show that opposite to hypertonic-induced hypertrophy, MNCs can undergo the 






















Figure 4.9: Hypo-osmolality evokes a reversible decrease in MNC size. Exposure to hypotonic 
PGC (n=9) causes acutely isolated MNCs to enlarge and shrink over 80 minutes. Returning the 
MNCs to isotonic PGC results in a rapid reversal of hypotrophy to the control CSA. The period of 














4.9 Immunofluorescence of L-type Ca2+ subunit CaV1.2 in MNCs, increases after hypertonic 
exposure  
It is known that chronically dehydrated rats have increased L-type Ca2+ current density (Zhang et 
al., 2007a) and the CaV1.2 subunit is expressed in MNC soma and dendrites (Glasgow et al., 1999; 
Joux et al., 2001). We therefore employed immunocytochemical techniques to measure the density 
of CaV1.2 subunits in MNCs after exposure to hypertonic PGC. Acutely isolated MNCs were 
treated with isotonic PGC, hypertonic PGC (325 mosmol kg-1) or hypertonic PGC with TTX for 
120 minutes. A protocol for immunolabeling fixed MNCs with antibodies against CaV1.2 was used 
to quantify the difference in expression between the treatment groups. The qualitative pictures of 
MNCs stained in different treatments is presented below in Figure 4.10 showing the MNCs with 
diffuse staining of CaV1.2 subunits on the cell plasma membrane and cytosol. The MNCs treated 
with hyperosmolar treatment showed higher immunostaining than the MNCs treated with isotonic 
solution. As shown in Figure 4.11, the mean fluorescence intensity of hypertonic PGC treated 
MNCs was 37.2 ± 15.6% (n=64) higher than the MNCs treated with isotonic PGC (n=68) (62.4 ± 
6.2 to 85.6 ± 9.7 arbitrary units/µm2) and was statistically different (using a one-way repeated 
measures analysis of variance test; P < 0.05). The mean fluorescence intensity of hypertonic PGC 
with TTX treated MNCs was 28.4 ± 12.2% (n=70) higher than the MNCs treated with isotonic 
PGC (n=68) (62.4 ± 6.2 to 80.1 ± 7.6 arbitrary units/µm2) and was statistically different (using a 
one-way repeated measures analysis of variance test; P < 0.05). The mean fluorescence intensities 
of hypertonic PGC treated MNCs with and without TTX were not significantly different (using a 
one-way repeated measures analysis of variance test; P > 0.05). The results suggest that there is an 
increase in CaV1.2 expression in MNCs exposed to hypertonic PGC, which does not depend on 





Figure 4.10: Pictures of MNCs showing increased immunofluorescence of the CaV1.2 subunit 
after hypertonic exposure. Representative MNCs exposed to different treatments are shown as 
DIC images and fluorescent images. The top row shows the MNCs through a DIC filter while the 
bottom row green colour represents MNC immunostaining with a CaV1.2 subunit antibody. The 





Figure 4.11: Bar graph of MNCs showing increased immunofluorescence of the CaV1.2 
subunit after hypertonic exposure. The bar graphs show the normalized mean fluorescence to 
CaV1.2 antibody in MNCs exposed to different treatments. Data are expressed as mean normalized 
fluorescence ± SEM. Hypertonic exposure causes a significant increase in CaV1.2 expression 
compared to isotonic treated MNCs. The addition of TTX to hypertonic exposure does not 
statistically affect the expression of the Cav1.2 subunit. The asterisks represent a statistical 









CHAPTER 5: DISCUSSION 
 
 
The structural adaptations of MNCs under chronic osmotic stress is poorly understood, due in part 
to the difficulty in elucidating the mechanisms in an in vivo preparation. Our lab has recently 
established an in vitro preparation using acutely isolated MNCs, which was used to 
pharmacologically assess the osmotically-evoked hypertrophy (Shah et al., 2014). MNCs were 
exposed to sustained increases in osmolality and it was observed that in addition to the acute 
shrinkage, MNCs can hypertrophy over the course of tens of minutes (Shah et al., 2014). This 
effect was dose-dependent, as decreases in the osmolality of the hypertonic solution results in 
comparable decreases in shrinkage and hypertrophy. Exposing the MNCs to hypotonic solution 
resulted in an immediate enlargement followed by a sustained decrease in cell size. It was also 
concluded that recovery from hypertrophy requires dynamin-dependent endocytosis. Further 
experimentation revealed that osmotically-evoked hypertrophy is independent of NKCC1 
activation (involved in cell volume regulatory processes), requires activation of PLC, PKC, cell 
depolarization and increases in [Ca2+]i. An in vitro preparation of acutely isolated MNCs exposed 
to hypertonic conditions for 120 minutes has shown increased immunolabeling of the L-type Ca2+ 
channel subunit, CaV1.2, which could be the result of increased channel subunit synthesis. This 
chapter will further elaborate on the findings revealed in this thesis and will attempt to draw 
physiological implications to the roles of these adaptations in neuroendocrine cells. 
 
5.1 Osmotically-induced structural changes 
 
During acute phases of hypertonic or hypotonic stress, the MNCs, like most other cell types, 
undergo acute cell volume shrinkage and enlargement, respectively (Lang et al., 1998a; Lang et 
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al., 1998b; Zhang & Bourque, 2003; Lang, 2007). The MNCs only return to their original cell 
volume, when re-exposed to isotonic conditions (Zhang & Bourque, 2003). This is in contrast to 
other neuronal cell types such as hippocampal neurons which undergo a dynamic RVI or RVD in 
order to compensate for the changes evoked by acute osmotic stress (Lang et al., 1998a; Lang et 
al., 1998b; Zhang & Bourque, 2003). In MNCs, the lack of compensatory volume regulatory 
processes affords the cell the ability to transduce changes in ECF osmolality into changes in 
membrane potential (Zhang & Bourque, 2003). The cells of the SON, MNCs and astrocytes, are 
also able to structurally adapt to sustained hypertonic exposure (Hatton, 1997). Chronic 
dehydration caused by salinized drinking water results in a 170% increase in MNC surface area in 
electron micrographs (Modney & Hatton, 1989). Chronic hypotonic conditions have been shown 
to display the opposite effect including sustained decreases (~40%) in cellular and nuclear size 
(Zhang et al., 2001). These changes in the structure of the MNCs and ultimately the SON are 
thought to occur to ensure long-term hormonal output during times of chronic osmotic stress 
(Hatton, 1997). 
 
5.1.1 Osmotically-evoked hypertrophy occurs in vitro and depends on specific cellular 
processes 
 
Data from previous lab members suggests that hypertrophy is dependent on specific cellular 
activities (Shah et al., 2014). The preincubation of MNCs with several blockers such as TTX, 
SB366791 and nifedipine in hypertonic solution resulted in shrinkage and recovery but no 
hypertrophy (Shah et al., 2014). This suggests that hypertrophy requires action potential firing, 
activation of the SIC channel, and influx of Ca2+ through L-type Ca2+ channels (Shah et al., 2014). 
Furthermore, adding these blockers to hypertrophied cells resulted in rapid reversal of the 
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hypertrophy, suggesting MNCs must maintain these processes to maintain hypertrophy (Shah et 
al., 2014). Finally, in an effort to understand the mechanism of enlargement, the role of exocytosis 
was further probed by incubating the MNCs in hypertonic solution with a peptide, TAT-NSF700, 
which is an inhibitor of SNARE-mediated exocytotic fusion (Shah et al., 2014). It was noted that 
the TAT-NSF700 peptide prevented hypertrophy, suggesting that the cell enlargement in 
hypertrophy is due to insertion of intracellular membrane (Shah et al., 2014). This finding was 
confirmed electrophysiologically by showing that the capacitance of MNCs treated with 
hypertonic PGC for 2 hours was significantly higher than the capacitance of MNCs in isotonic 
PGC (Shah et al., 2014).  
 
As stated, the SIC activation and generation of action potentials is necessary for the cells to initiate 
and maintain hypertrophy (Shah et al., 2014).  Thus, even though the MNCs hypertrophy, the SIC 
is still able to remain activated (Shah et al., 2014). A possible explanation for this is that the SICs 
are remaining active by some other mechanism. This mechanism may include mediators which 
serve to directly activate the SICs or may involve the reduction of the inhibitory influence of 
channel modulating agents, possibly PIP2 (Brauchi et al., 2007; Rohacs et al., 2008; Ufret-
Vincenty et al., 2011). In addition, during membrane insertion while the MNCs hypertrophy, there 
may be translocation of SICs which may lead to an increase in SIC currents (Morenilla-Palao et 
al., 2004). This sustained activation of the SIC can explain the depolarization required to facilitate 
action potential firing, even in the hypertrophied state.  
 
It is interesting to note that the in vivo studies show that MNC hypertrophy can occur up to about 
170% (Modney & Hatton, 1989) in MNC size, however this in vitro preparation shows only a 5% 
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increase in CSA. This discrepancy can be due to many reasons such as time of exposure and also 
by the absence of surrounding astrocytes in the acutely isolated preparation, which may release 
factors involved in hypertrophy (Shah et al., 2014). For example, it is known that the astrocytes 
surrounding MNCs release ATP which can act on purinergic P2X7 receptors on MNCs to increase 
excitatory postsynaptic potentials (Gordon et al., 2009). Thus the presence of astrocytes may 
enhance the hypertrophy response as seen in vivo via the release of ATP. In addition, the in vivo 
preparation consists of closely packed MNCs and so somatodendritic release of certain autocrine 
or paracrine mediators such as dynorphin (Whitnall et al., 1983; Simmons et al., 1995) and VP 
(Ludwig & Leng, 1997; Ludwig, 1998b) could also enhance the hypertrophy response.  
 
In addition, capacitance measurements measured in the lab show an increase of 7% in hypertonic 
conditions (325 mosmol kg-1), however there is an 11% increase from the shrunken CSA to the 
hypertrophied CSA (Shah et al., 2014). The lower increase in capacitance may reflect the fact that 
whole-cell capacitance represents total membrane surface area including the MNC soma and 
dendrites (Shah et al., 2014). With this rationale, increasing the cell soma size by a certain amount 
would therefore result in a lower increase in total membrane surface area and thus whole-cell 
capacitance (Shah et al., 2014). Finally, the MNCs contain processes and are not perfect spheres 
thus increases in CSA may not accurately translate into increases in total membrane surface area 
(whole-cell capacitance).  
 
The results discussed were obtained previously by other lab members. I will now discuss the results 




5.1.1.1 Hypertrophy of MNCs is dose-dependent 
 
When MNCs were treated with 325 mosmol kg-1 hypertonic PGC, they immediately shrunk on 
average to about 94.5% of their control CSA and maintained their volume for about 20 minutes, 
after which they started to hypertrophy. This finding is agreement with studies showing that MNCs 
shrink immediately and remain shrunk over the course of 10 minutes, suggesting they do not 
undergo acute cell volume regulation (Zhang & Bourque, 2003). The increase in osmolality was 
sustained and it was observed that over the course of 90 minutes the MNC cell soma increases to 
about 105.2%. This observation is also in agreement with studies showing dehydration lasting as 
little as 2 hours can induce hypertrophy in the MNC soma in vivo (Hatton & Walters, 1973). Upon 
re-introducing isotonic PGC, the MNCs rapidly recovered to the control CSA, a finding that is in 
agreement with the reversibility of MNC soma hypertrophy (Hatton, 1997). An interesting finding 
within this study is that hypertrophy occurs at more physiological increases in ECF osmolality as 
evident by a reduced shrinkage and hypertrophy in MNCs exposed to 305 and 300 mosmol kg-1 
hypertonic PGC. This suggests that hypertrophy occurs at physiological ranges and that the 
response is sensitive to even small changes in osmolality. This finding suggests that osmotically-
evoked hypertrophy may occur on a day-to-day basis. This dynamic regulation of MNC size and 
perhaps excitability may regulate the VP output and overall fluid balance. 
 
5.1.1.2 Hypertrophy does not involve NKCC1-mediated cell volume regulation 
 
Osmosis dictates that water will only flow from hypotonic to relatively hypertonic compartments 
to equalize the osmolality (Boron & Boulpaep, 2008). Under hypertonic conditions, the MNCs 
hypertrophy, which is known to require SNARE-mediated exocytotic fusion of membrane (Shah 
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et al., 2014). Despite the addition of membrane, the increase in cell volume requires regulation of 
cytoplasmic osmotic strength to enable the increase in intracellular water content (Lang et al., 
1998a; Lang et al., 1998b; Lang, 2007; Shah et al., 2014). Thus the cell must ultimately increase 
the osmotic strength of its cytoplasm by increasing the concentration of ions and organic molecules 
(Lang et al., 1998a; Lang et al., 1998b; Lang, 2007). It was therefore important to address this 
issue to see if ion transporters involved in RVI could be involved in hypertrophy. NKCC1, a 
Na+/K+/Cl- co-transporter, is a major accumulator of ions in RVI (Lang et al., 1998a; Lang et al., 
1998b). When MNCs were exposed to hypertonic PGC in the presence of bumetanide, there was 
no significant difference in CSAs when compared to MNCs exposed to hypertonicity without 
bumetanide. This effect was important since NKCC1 is involved in RVI, and thus these finding 
suggest that if hypertrophy involves sequestration of ions in the cytosol, then it is not through 
activation of NKCC1. Since hypertrophy involves insertion of membrane at the surface, there 
could be translocation of certain ionic and organic molecule transporters to increase the 
intracellular osmotic strength and water content resulting in cell volume expansion. Further studies 
in this in vitro preparation need to carefully examine the role of other ionic transporters in 
hypertrophy. In addition, it is known that chronic hypertonic stress causes upregulation of several 
genes (Glasgow et al., 2000; Burbach et al., 2001; Yue et al., 2006). It is thus possible that an 
increase in intracellular osmolality may be provided, in part, by an increase in gene expression. 
Our studies on the effect of hypertonicity on L-type Ca2+ channels have shown that a short two 
hour exposure is sufficient to cause a significant increase in the synthesis of the CaV1.2 subunit. 
Thus other genes controlled by similar gene upregulation pathways can also be rapidly increased 
and contribute to the increase in intracellular osmolality. Further, endogenous synthesis of other 
types of biomolecules could also contribute to an increase in intracellular osmolality. Additional 
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experiments should be performed to understand whether rapid synthesis of proteins and other 
biomolecules are important in contributing to the increase in intracellular osmolality and MNC 
hypertrophy. 
 
5.1.1.3 Dynamin-dependent endocytosis governs the MNC recovery from hypertrophy 
 
The hypertrophy of MNCs occurs through exocytotic fusion of intracellular membranes as 
confirmed by pharmacological and electrophysiological observations in our preparation (Shah et 
al., 2014). During acute hypertonic stress, the MNCs shrink in size as water rushes out of the AQP 
channels to equalize the osmolality (Zhang & Bourque, 2003; Boron & Boulpaep, 2008). Once the 
MNCs undergo exocytotic increases in membrane and hypertrophy, there must be a mechanism to 
revert back to the normal isotonic CSA. Many neuronal cells exhibit reversible structural and 
functional adaptations with exocytosis and endocytosis acting as a mechanistic “switch”. An 
example is in long-term potentiation (LTP) during which AMPARs are translocated in the 
postsynaptic membrane to sustain excitatory post synaptic potentials (Lu et al., 2001). During 
long-term depression (LTD), the AMPARs are not required and thus the neuron activates dynamin-
dependent endocytotic machinery to reduce their presence on the membrane (Beattie et al., 2000). 
A similar process may exist within the MNCs as hypertrophy may be analogous to LTP (increased 
channels and receptors) to sustain high amounts of hormonal output, while recovery from 
hypertrophy may be analogous to LTD by withdrawing membrane (including receptors and 
channels) and thus decreasing neuronal volume. In order to test this hypothesis, a blocker of 
dynamin-dependent endocytosis, dynasore, was employed to study recovery from MNC 
hypertrophy (Macia et al., 2006; Kirchhausen et al., 2008). Dynamin is a GTPase that is the final 
requirement to pinch off the invaginations to form intracellular vesicles (Morlot & Roux, 2013). 
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It was observed that MNCs exposed to hypertonic PGC with dynasore did not differ in any 
parameter of the hypertrophy (time course, maximal CSA) but failed to recover after re-exposure 
to isotonic PGC. This suggest that recovery from hypertrophy is a plasma membrane trafficking 
event that involves dynamin-dependent endocytosis to decrease the MNC CSA. An interesting 
feature of the recovery in dynasore-treated MNCs is the rapid transient decrease in cell size, 
followed by a gradual return to the hypertrophied cell size. This is very similar, in non-dynasore-
treated MNCs, to the rapid decrease and overshoot in cell size, followed by a steady return to the 
control size. We do not understand these observations and future studies should aim to resolve 
these idiosyncrasies in the recovery response. 
 
5.1.1.4 Activation of the PLC-PKC pathway is required for MNC hypertrophy 
 
Hypertonic stress activates a wide variety of protein kinases and phospholipases in non-neuronal 
cells (Munnik et al., 2000b; Droillard et al., 2002; Rodriguez et al., 2002; Fujii & Zhu, 2012). The 
phospholipid PIP2 is a very important modulator of several ion channels especially TRP channels 
and M-type K+ channels (Hilgemann et al., 2001; Suh & Hille, 2005). It has been recently 
demonstrated that acute hypertonic stress activates PLC in MNCs, resulting in a ~30% decrease in 
surface PIP2 levels (Shah et al., 2014). PKC is involved in translocation of TRPV1 in oocytes 
(Morenilla-Palao et al., 2004) and Ca2+ channels in Aplysia bag cell neurons (Strong et al., 1987). 
Further studies have shown translocation of several channels and receptors in MNCs during 
chronic hyperosmotic stress, including Na+ channels (Tanaka et al., 1999), V1a receptors (Hurbin 
et al., 2002), dynorphin receptors (Shuster et al., 1999) and L-type Ca2+ channels (Zhang et al., 
2007a). These data warrant further investigation in MNCs for the role of PLC and PKC activation 
in triggering hypertrophy. It was observed that MNCs treated with hypertonic PGC in the presence 
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of an inhibitor of either PLC or PKC, did not hypertrophy, suggesting their activation is required 
for the hypertrophic response. Further, it was shown that treating the MNCs with a PKC activator 
in the presence of isotonic PGC resulted in a mild hypertrophic response. The smaller size of the 
PKC activator-induced hypertrophy suggests that other triggers are required for the full 
hypertrophic response such as increased [Ca2+]i. Since the MNC osmosensitivity requires TRPV1 
channels (Zhang et al., 2007b; Sharif-Naeini et al., 2008) and also since Ca2+ channels are found 
in intracellular granules of MNCs (Fisher et al., 2000), it is possible that hypertrophy leads to 
translocation of these channels resulting in hypertrophy and modulation of MNC 
electrophysiology.  
5.1.1.5 Cell depolarization and Ca2+ influx can cause MNC hypertrophy 
 
 
Previous data from the lab suggested that MNC hypertrophy requires action potential firing and 
Ca2+ influx through L-type Ca2+ channels for the initiation and maintenance of hypertrophy (Shah 
et al., 2014). The ability of cell depolarization and influx of Ca2+ through an ionophore was further 
investigated to establish whether these events are sufficient to trigger hypertrophy in the absence 
of an increase in osmolality. To probe the effects of cell depolarization, an isotonic PGC containing 
high K+ (25 mM) was used to cause cell depolarization. It was shown that MNCs treated with a 
high K+ isotonic PGC rapidly hypertrophied and recovered when they were reintroduced to 
normokalemic isotonic PGC. Furthermore, this effect was negated by the addition of a PLC 
inhibitor to the high K+ isotonic PGC, suggesting PLC is activated downstream of cell 
depolarization and is required for the depolarization to cause an hypertrophy. Secondly, a Ca2+ 
ionophore, A23187, was used to rapidly increase [Ca2+]i and probe whether it is sufficient to cause 
hypertrophy. MNCs exposed to the Ca2+ ionophore in isotonic PGC showed a rapid hypertrophy 
but were not able to recover when re-exposed to isotonic PGC without the Ca2+ ionophore. The 
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inability to recover from hypertrophy after addition of the Ca2+ ionophore is expected since the 
ionophore cannot be removed from the membrane (Herth, 1978; Hadley, 1987) probably due to its 
lipophilic nature (Reed & Lardy, 1972; Klausner et al., 1979). It would also be useful to see if 
treatment with EGTA or BAPTA-AM to buffer internal Ca2+ could prevent hypertrophy. In 
addition, to further confirm that the increase in [Ca2+]i is indeed the trigger (and not cell damage), 
the Ca2+ ionophore maybe co-administered with an inhibitor of PLC or PKC. These data suggest 
that hypertonicity-induced hypertrophy requires cell depolarization-induced Ca2+ influx, and the 
activation of PLC and PKC, and exocytotic fusion.  
 
5.1.1.6 Hypotonicity evokes reversible hypotrophy in MNCs 
 
A study documenting the effects of long-term in vivo hypotonicity in MNCs showed that MNC 
soma and nuclear sizes decreased 40% in size (Zhang et al., 2001). This effect is opposite to what 
is seen during chronic hypertonic conditions and is interesting that MNCs are able to adapt to a 
wide variety of osmotic stresses in opposite ways. This finding is still poorly studied and the 
mechanisms underlying the decrease in cell size should be further investigated. The acutely 
isolated MNC preparation was used to explore whether the in vivo results can be replicated in vitro. 
The MNCs were exposed to hypotonic PGC (280 mosmol kg-1) and showed immediate cellular 
enlargement, as expected (Zhang et al., 2001). During a course of 75 minutes, however, the MNCs 
gradually decreased in cell size. The decrease in the MNCs cell size was sustained, but they 
recovered to their control CSA upon returning to isotonic conditions. Thus the in vivo results could 
be replicated and the in vitro preparation can be further used to describe the mechanism of this 




5.2 Osmotically-induced functional changes  
 
The structural adaptations described above are part of the functional adaptations that help to 
modulate the electrical firing pattern and hormonal output (Hatton, 1997). These changes include 
upregulation of specific ion channels and receptors on the cell membrane and expression of genes. 
The V1a receptor is upregulated at the MNC plasma membrane and it serves to detect the increased 
VP output and inhibit phasic firing in MNCs (Petersen, 2006). Na+ channels (Tanaka et al., 1999) 
are also translocated to the cell surface and this may alter the electrophysiological properties and 
phasic firing patterns. Translocation of dynorphin receptors occurs and their role involves 
decreasing Ca2+ influx and thus decreasing neuropeptide release (Shuster et al., 1999; Brown & 
Bourque, 2004, 2006). In terms of genes, several genes involved in general cell metabolism, 
housekeeping and cytoarchitecture are upregulated in order to prepare the MNC for sustained 
output of hormones (Glasgow et al., 2000; Burbach et al., 2001; Yue et al., 2006).  
 
5.2.1 Immunostaining of CaV1.2 L-type Ca2+ channel subunit increases in MNCs exposed to 
sustained hypertonicity 
 
L-type Ca2+ channels with subunits CaV1.2 and CaV1.3 have been identified in MNCs (Glasgow 
et al., 1999; Joux et al., 2001). These L-type Ca2+ channels are found on the membranes of the 
soma and dendrites (Fisher & Bourque, 1995; Joux et al., 2001; Zhang et al., 2007a) and there also 
exists an internal pool of VGCCs that may include L-type Ca2+ channels (Fisher et al., 2000). A 
study from our lab has demonstrated that rats dehydrated overnight show an 80% increase in L-
type Ca2+ currents using whole-cell patch clamp (Zhang et al., 2007a). It is also known that Ca2+ 
currents do not increase immediately following exposure to hypertonic solutions (Liu et al., 2005). 
The results from this study document that exposing MNCs to hypertonic solution for 2 hours 
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causes an increase in CaV1.2 immunostaining of about 37%.  This increase was not blocked by 
addition of TTX suggesting that action potential firing is not required for the increase in the CaV1.2 
subunit. 
 
The increase in CaV1.2 immunolabeling suggests an increase in channel number, however, 
microarray analysis, did not show an increase in any Ca2+ channel mRNA following dehydration 
(Hindmarch et al., 2006) and RT-PCR did not show an increase in mRNA of L-type Ca2+ channels 
(Zhang et al., 2007a). Thus a possible explanation could be that there is an increase in protein 
translation as the mammalian target of rapamycin (mTOR), a regulator of protein synthesis (Hay 
& Sonenberg, 2004), is shown to be activated by hyperosmotic stress in HEK293 cells (Kwak et 
al., 2012). In our in vitro immunocytochemical study, translocation was difficult to examine due 
to the inability to discern cytoplasmic immunolabeling from plasma membrane immunolabeling 
as the staining was diffuse. VGCCs are expressed in intracellular vesicles in MNCs and 
translocation of these channel reserves could be possible (Fisher et al., 2000). 
 
5.3 Physiological consequences of MNC hypertrophy and increases in CaV1.2 subunit 
 
The sustained dehydration in rats results in increases in MNC soma size in vivo (Hatton & Walters, 
1973), and increases in channels and receptors on the plasma membrane (Shuster et al., 1999; 
Tanaka et al., 1999; Hurbin et al., 2002; Zhang et al., 2007a). Using the in vitro preparation, we 
may be finally beginning to understand the mechanisms of MNC hypertrophy (Hatton, 1997). 
Based on our findings in the lab, we can offer a preliminary model of the hypertonicity-induced 
MNC hypertrophy. During the initial phases of hypertonic exposure, MNCs will undergo 
immediate shrinkage, which is proportional to the increase in osmolality of the hypertonic solution 
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(Lang et al., 1998a; Lang et al., 1998b; Zhang & Bourque, 2003). The initial shrinkage will result 
in activation of SICs, which will allow influx of cations into the MNC and cause depolarization, 
and facilitate the generation of action potentials (Zhang et al., 2007b; Sharif-Naeini et al., 2008). 
The action potentials will cause high threshold L-type Ca2+ channels (Simmons et al., 1995; 
Lipscombe et al., 2004; Zhang et al., 2007a) to open and cause an influx and rise in [Ca2+]i. The 
rise in [Ca2+]i will lead to activation of PLC, which will cleave PIP2 into IP3 and DAG (Rebecchi 
& Pentyala, 2000; Irino et al., 2004). The IP3 may act to mobilize Ca
2+ from intracellular stores in 
the ER (Rebecchi & Pentyala, 2000; Irino et al., 2004). The DAG will bind to and activate PKC, 
which has been implicated in exocytosis and translocation of many channels and receptors 
(Morenilla-Palao et al., 2004; Morgan et al., 2005). 
 
From our data it is known that osmotic activation of PLC results in PKC activation. The activation 
of PKC has been widely implicated in the fusion of vesicles (Naor et al., 1989; Morgan & 
Burgoyne, 1992; Morgan et al., 2005) and translocation of several channels and receptors (Strong 
et al., 1987; Morenilla-Palao et al., 2004). In addition, several studies in MNCs have shown that 
chronic hypertonicity involves upregulation of several channels and receptors including V1a 
receptors (Hurbin et al., 2002), Na+ channels (Tanaka et al., 1999) and dynorphin receptors 
(Shuster et al., 1999) which are all involved in the MNC electrophysiology and hormonal output 
(Ludwig, 1998b; Brown & Bourque, 2004; Brown et al., 2004). Thus these findings lead to the 
possibility that the osmotically-evoked hypertrophy, via PKC-mediated fusion of intracellular 
membranes, can cause translocation of certain channels and receptors to modulate the activity of 
MNCs and allow functional adaptation for long-term hormonal output. Finally during recovery, 
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there seems to be an activation of dynamin-dependent endocytotic mechanisms, which serves to 
rapidly retract the membrane resulting in the recovery of MNC cell size.  
 
The L-type Ca2+ channels have a prominent role in MNC neuropeptide secretion and possibly gene 
transcription (Dolmetsch et al., 2001a), and so can be part of functional adaptations to chronic 
hypertonicity (Fisher & Bourque, 1995, 1996; Fisher et al., 2000; Fisher & Bourque, 2001). It is 
well known that Ca2+ influx through L-type Ca2+ channels can activate CREB and increase 
transcription of various genes (Bading et al., 1993; Ginty et al., 1993) and this could be part of the 
long-term response to chronic hypertonicity. The L-type Ca2+ channels possess two very important 
sequences that afford them the ability to activate CREB. The first sequence is the in the C-terminus 
of CaV1.2 and CaV1.3 subunits, which interacts with anchoring proteins to position them so that 
they activate CREB (Dolmetsch et al., 2001b; Zhang et al., 2006). The other site interacts with 
calmodulin and with the addition of Ca2+, can result in its activation, resulting in translocation to 
the nucleus and phosphorylation of CREB (Deisseroth et al., 2003).  
 
Somatodendritic release of VP and OT regulates the efficacy of synapses onto the MNCs and 
somatodendritic release of VP, OT, and other peptides (including dynorphin) regulate MNC firing 
patterns (Ludwig & Leng, 1997; Ludwig, 1998a; Sladek, 2004). It is known that dynorphin 
receptors undergo translocation to the cell membrane in dehydrated rats (Shuster et al., 1999) and 
also in hippocampal neurons, L-type Ca2+ channels regulate somatodendritic release of dynorphin 
(Simmons et al., 1995). Thus the increase in L-type Ca2+ channels seen during chronic dehydration 
may be part of a functional adaptation which leads to enhanced release of peptides such as 
dynorphin to regulate MNC electrical activity along with increasing release of neuropeptides OT 
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and VP. In addition, blockers of L-type Ca2+ channels reduced depolarization-induced 
somatodendritic OT release (Tobin et al., 2011), and thus L-type Ca2+ channels may have a role in 
somatodendritic neuropeptide release. Also, the phasic burst firing patterns are important for the 
sustained release of MNC neurohypophysial hormones (Poulain & Wakerley, 1982). It is well 
known that the Ca2+ is a regulator of the depolarizing (DAP) and hyperpolarizing (HAP, AHP) 
after potentials and influx through of Ca2+ through L-type Ca2+ channels may have a role in 
increasing their currents (Andrew & Dudek, 1983; Armstrong et al., 1994). The increase in CaV1.2 
seen in our in vitro model suggests that this may be important in gene upregulation and enhanced 
hormonal synthesis and release during conditions of hyperosmotic stress.  
5.4 Future directions 
 
The significance of osmotically-induced hypertrophy remains unknown. We suggest that 
hypertrophy involves insertion of membranes to the cell surface that may include membrane-
associated proteins and channels. These may be Ca2+ channels (Zhang et al., 2007a), 
mechanosensitive cation channels (Morenilla-Palao et al., 2004) or even Na+ channels (Tanaka et 
al., 1999). Thus the insertion of these channels may modulate the electrical activity of MNCs, 
which could be important in the long-term release of VP. Subsequent investigations could include 
patch clamp electrophysiology to understand whether chronic exposure to hypertonic solutions can 
modulate the electrophysiology of MNCs by changes in the density of ion channels and proteins. 
Immunocytochemical techniques can be employed to quantify changes in abundance of surface 
level proteins and channels after exposure to hypertonic solution.  
 
In addition, it will be important to understand the mechanism of osmotically-induced hypertrophy, 
specifically by investigating the source of the membrane and the mechanisms that mediate its 
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insertion. Live cell fluorescence of MNCs with organelle specific dyes can be used to visualize 
where the membrane comes from. Notable dyes include Hoechst 33342 and ER-Tracker-Red for 
staining and visualizing the dynamic movement of nuclear and ER membranes, respectively. In 
addition, it can be hypothesized that the membranes come from vesicles containing channels and 
receptors from the Golgi apparatus and thus blocking protein trafficking from the Golgi using 
Brefeldin A might block osmotically-evoked hypertrophy.  
 
As described, in addition to insertion of new membrane, an increase in cell volume must 
accompany an increase in intracellular osmolality. Further studies should investigate the 
mechanisms involved, which serve to increase the intracellular osmotic strength. This may include 
using blockers of ionic and organic molecule transporters to see if hypertrophy is affected. In 
addition, if hypertrophy results in translocation of transporters to the membrane then 
immunocytochemical studies can be used to document which transporters are involved. 
 
The transient response seen during recovery with and without dynasore should be further probed 
to understand why the cell undergoes a rapid and overshooting decrease in cell volume followed 
by a gradual return to the control size. These studies should investigate the kinetics of endocytosis 
and also the rapidity of ion and water efflux.  
 
Our data on the mechanisms involved in hypertrophy in vitro will help us to develop tools to test 
whether similar mechanisms underlie hypertrophy in vivo. In order to effectively translate in vitro 
findings into more functionally applicable data, an in situ model of the SON should be used. 
Specifically, stereotaxic procedures can be used to perform bilateral infusions of various drugs 
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(action potential blockers and exocytotic fusion blockers) into one SON and a control vehicle in 
the contralateral SON. Subsequently, structural changes of the SON after a hyperosmotic challenge 
can be observed or the overall regulation of fluid balance (plasma VP levels and osmolality) can 
be measured. 
 
Finally, the observation that acutely isolated MNCs hypotrophy under chronic hypotonic 
conditions as in vivo (Zhang et al., 2001), warrants further investigation into the mechanism of the 
response. It may be that the decrease in size is due to dynamin-dependent endocytosis while the 
recovery involves exocytosis. Thus these mechanisms can be further probed by using dynasore 
and TAT-NSF700 to see whether the hypotrophy response or recovery can be blocked by their 
presence, respectively.  
 
The increase in L-type Ca2+ channel subunit CaV1.2 is an important finding suggesting the role of 
Ca2+ and L-type Ca2+ channels in the long-term adaptations of MNCs in chronic hypertonic stress. 
In hypertrophy, the enlargement of MNCs is dependent on activation of SICs and Ca2+ influx (Shah 
et al., 2014). Further studies should investigate whether blocking the SICs (SB366791) and 
chelating intracellular Ca2+ (BAPTA-AM) will prevent the increase in CaV1.2 expression. Further, 
it was not possible to discern the abundance of CaV1.2 between the MNC plasma membrane and 
cytoplasm due to the diffuse staining. Further experiments to investigate translocation can include 
fluorescently labeled dihydropyridines to visualize the location of the channels (Knaus et al., 
1992). Finally the increase in CaV1.2 subunit seen in our studies is not paralleled with an increase 
in mRNA of L-type Ca2+ channels and this finding can argue for an increase in protein synthesis 
(Zhang et al., 2007a). The same experiments described in this study can be performed in the 
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presence of blockers of protein synthesis such as rapamycin and cyclohexamide. These subsequent 
studies will help to elucidate the mechanisms underlying this interesting example of 





































CHAPTER 6: CONCLUSION 
 
 
The MNCs of the SON have been known to undergo a remarkable soma hypertrophy, when 
exposed to chronic hyperosmotic stress in vivo. These in vivo findings are confirmed in an in vitro 
model showing that MNCs initially shrink, but undergo a reversible hypertrophy over the course 
of 90 minutes. Further, it has been shown that hypertrophy is dose-dependent, independent of cell 
volume regulation, dependent upon activation of PLC and PKC, can be induced by depolarization 
and increasing [Ca2+]i, and that recovery from hypertrophy depends upon dynamin-mediated 
endocytosis. In addition, it has been seen that under chronic hypotonic conditions, MNCs initially 
enlarge followed by a steady and sustained decrease in MNC soma size.  Finally, it has been shown 
that MNCs exposed to hypertonic conditions for two hours, have increased expression of the L-
type Ca2+ channel CaV1.2 subunit, similar to an increase in L-type Ca
2+ current density in MNCs 
from overnight dehydrated rats. This thesis has documented the effects of chronic hypertonicity 
on MNC structure and abundance of the L-type Ca2+ channel CaV1.2 subunit. These findings will 
help us to understand the mechanisms of the important structural and functional neuroendocrine 
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